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Obstructive sleep apnea (OSA) is a sleep related breathing abnormality that involves snoring and 
intermittent breathing pauses. In children, OSA is linked to cardiovascular, metabolic, 
behavioural, neurocognitive, and academic consequences (Blechner & Williamson, 2016; Tan, 
Gozal, & Kheirandish-Gozal, 2016). The most common causes of childhood OSA are 
adenotonsillar hypertrophy and obesity. With the increasing prevalence of childhood obesity, 
screening for OSA in the primary care setting is essential for early recognition. This integrative 
review is guided by the research question: what strategies can NPs, as primary care providers, 
implement to improve screening for OSA in children between the ages of 2-8 years to determine 
need for referral? A comprehensive literature search was conducted, and 11 pertinent articles 
were identified to address the research question. During analysis, three major themes to improve 
childhood OSA screening emerged: 1) use of validated pediatric OSA screening questionnaires; 
2) use of subjective and objective variable screening tools; and 3) the feasibility of home-based 
nocturnal oximetry for children with suspected OSA. Synthesis of the literature provides tools 
primary care providers can use to screen children for OSA, as well as multiple subjective and 
objective clinical features of childhood OSA. A gap in pediatric sleep services is recognized, 
which places emphasis on the need for improved childhood OSA screening in the primary care 
setting. Further research is needed to validate the use of home-based nocturnal oximetry sleep 
studies for children with suspected OSA. This paper is concluded with additional 
recommendations for practice, education, and public health to improve childhood OSA screening 
and achieve early recognition.
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 Obstructive sleep apnea (OSA) is a sleep related breathing abnormality that involves 
snoring and intermittent breathing pauses. OSA is estimated to affect 1.2-5.7% of otherwise 
healthy children, however, due to poor awareness this disease often goes unrecognized and 
untreated in early childhood (DelRosso, 2016; Marcus et al., 2012). Untreated, OSA poses a 
serious threat to the growth and development of children, as it is associated with negative 
cardiovascular, metabolic, behavioural, neurocognitive, and academic consequences (Blechner & 
Williamson, 2016; Marcus et al., 2012; Tan et al., 2016). Thus, it is essential for primary care 
providers to recognize children who are at risk for OSA, and ensure they receive prompt referral, 
diagnosis, and treatment. The American Academy of Pediatrics (AAP) clinical practice 
guidelines from 2002 and 2012 provide recommendations for the screening, referral, and 
treatment of childhood OSA (Marcus, Chapman, Ward, & McColley, 2002; Marcus et al., 2012). 
To screen for childhood OSA, the AAP recommend that primary care providers inquire about the 
presence of snoring at all routine health maintenance visits (Marcus et al., 2002; Marcus et al., 
2012). If a child snores on a regular basis, the updated 2012 AAP clinical practice guideline 
recommends the child be referred for polysomnography (PSG), or to a sleep specialist or 
otolaryngologist to assess for OSA (Marcus et al., 2012). Despite these recommendations, there 
is poor screening and recognition of childhood OSA at the primary care level (Ipsiroglu et al., 
2009; Marcus et al., 2012).  
 The problem with addressing OSA in children is two-fold. Firstly, primary care providers 
lack experience and expertise in screening children for OSA (Mindell et al., 2013; Mukherjee et 
al., 2015). Sleep medicine has only recently been identified as a subspecialty in medicine, and 
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knowledge of childhood sleep disorders is still under recognized (Ipsiroglu et al., 2009; Shepard 
et al., 2005). Thus, due to primary health care providers’ lack of sleep-related education, 
screening for childhood sleep disorders, including OSA, is often missed (Erichson et al., 2012; 
Faruqui, Khubchandani, Price, Bolvard, & Reddy, 2011; Mindell et al., 2013). Secondly, the 
gold standard for diagnosing children with OSA is PSG (DelRosso, 2016). PSG is resource 
intensive; requiring an overnight stay in a sleep laboratory, and in British Columbia, the only 
location for testing is in Vancouver at BC Children’s Hospital (BCCH). Furthermore, pediatric 
PSG services in BC often carry a minimum wait time of six months (Garde et al., 2014). 
Traveling to BCCH for PSG can be a significant burden for many families, especially those 
living in rural or Northern communities. Due to the burden of travel and limited access to 
resources, primary care providers must have a high level of suspicion for OSA in order to refer 
for PSG. 
 Nurse Practitioners (NP) are health professionals trained at the graduate level to provide 
primary care services including preventative screening, ordering diagnostic tests, prescribing 
medications and interventions, and referring to specialists when indicated (College of Registered 
Nurses of British Columbia [CRNBC], 2011). NPs in BC commonly practice in the primary care 
setting and are referred to—along with general practitioners/family physicians—as primary care 
providers. NP practice places great emphasis on health promotion and preventative health care, 
thus, NPs are in an optimal position to screen children for OSA, and determine which children 
require referral (CRNBC, 2011). 
 The purpose of this integrative review is to inform practice in the primary care setting 
related to screening children for OSA and determining which children require referral to 
specialists or for PSG. The population of interest is children aged 2-8 years of age in the primary 
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care setting. The 2-8 year old age group was chosen as it represents the peak prevalence of 
childhood OSA, which coincides with peak adenoid and tonsil growth (Bhattacharjee, Kim, 
Kheirandish-Gozal, & Gozal, 2011; DelRosso, 2016). Furthermore, the 2-8 year old age group is 
also a common age for the detection of neurodevelopmental issues that may be identified 
coinciding with the start of preschool or elementary school. Neurodevelopmental issues in 
school-aged children may be associated with disrupted sleep associated with OSA (Brockmann, 
Schaefer, Poets, Poets, & Urschitz, 2013b; DelRosso, 2016). Consequently, 2-8 year old children 
represent a population that demonstrate significant benefit from early recognition of OSA. The 
following research question will guide this integrative review: what strategies can NPs, as 
primary care providers, implement to improve screening for OSA in children between the ages of 
2-8 years to determine need for referral?  
 To address the research question, a comprehensive review of the literature was conducted 
and is presented in this integrative review. Chapter two will address the background and context 
of the components of the research question, providing further exploration of childhood OSA and 
the complexities of screening and diagnosis. Chapter three will introduce the methods of the 
search strategy to identify relevant literature. Chapter four will analyze the findings from the 
search strategy. Finally, chapter five will provide discussion and synthesis of the findings from 
this integrative review, along with key recommendations for childhood OSA screening in the 




Background and Context  
 Childhood obstructive sleep apnea (OSA) is linked to cardiovascular, metabolic, 
behavioural, neurocognitive, and academic consequences, which can significantly impact 
children and their parents’ quality of life (Blechner & Williamson, 2016; Tan et al., 2016). 
Childhood OSA has a prevalence between 1.2-5.7% of the general population, however, the 
diagnosis is often missed or delayed due to poor recognition of OSA, inferring that the rate could 
be higher (DelRosso, 2016; Marcus et al., 2012). In adults, OSA is a well-recognized and 
established disorder with clear indications for screening, diagnosis, and treatment. However, 
OSA in children remains under recognized. Over the past decade a growing interest in the field 
has resulted in research studies which have improved the understanding of the risk factors 
associated with children developing OSA, as well as the consequences of untreated OSA 
(Marcus et al., 2012; Tan et al., 2016). In 2007, a stakeholder consensus meeting was held at BC 
Children’s Hospital (BCCH) to discuss the gaps in pediatric sleep medicine within the province 
(Ipsiroglu et al., 2008). A proposal for a three-level sleep service in BC was recommended and 
included: 1) “public education at the primary health care level”; 2) “structured knowledge 
dissemination among professional and associated partners at the secondary health care level”; 
and 3) “structured knowledge generation and dissemination among professionals and associated 
partners at the tertiary health care level” (Ipsiroglu, 2008, p. 514). It is acknowledged that 
pediatric sleep services do not meet the needs of our population, and furthermore, there is a lack 
of public and primary care provider knowledge towards addressing childhood sleep disturbances 
(Ipsiroglu, 2008). In 2015, the American Thoracic Society released an official statement on the 
need for increased awareness of primary care providers and the general public in regards to the 
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importance of early recognition of childhood OSA because of the significant consequences of 
untreated OSA (Mukherjee et al., 2015). NPs as primary care providers have an important role in 
screening children for OSA and teaching children’s caregivers about signs and symptoms of 
OSA. The following section will further explore childhood OSA, in addition to the complexities 
of screening.  
Sleep Disordered Breathing, Obstructive Sleep Apnea, and Primary Snoring  
 Sleep disordered breathing (SDB) is an umbrella term for several chronic conditions in 
which breathing difficulties occur during sleep. The term SDB encompasses a spectrum of sleep-
related breathing abnormalities, ranging from primary snoring to the most severe form, 
obstructive sleep apnea (OSA; Garde et al., 2014). Childhood OSA is defined as “a disorder of 
breathing during sleep characterized by prolonged partial upper airway obstruction and/or 
intermittent complete obstruction (obstructive apnea) that disrupts normal ventilation during 
sleep and normal sleep patterns” (American Thoracic Society, 1995, p. 866). In the literature, 
SDB and OSA are often used interchangeably. For clarity, all children with OSA have SDB. 
However, all children with SDB are not found to have OSA. SDB is a broad term that is often 
used when OSA is suspected; a diagnosis of OSA requires PSG in addition to clinical 
correlation. Primary, or habitual snoring is a form of SDB, and is a common indication for OSA 
screening.  
 Snoring. Snoring is a harsh sound while breathing during sleep due to vibration of the 
soft palate (“snoring,” n.d.). As outlined by the AAP 2012 clinical practice guidelines, the first 
indicator to screen for OSA in the primary care setting is asking about the presence of snoring 
(Marcus et al., 2012). Snoring is present in nearly all children who have OSA, thus, the presence 
of snoring has great sensitivity towards predicting OSA; however, the specificity of snoring in 
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identifying OSA is less robust. Habitual snoring is the presence of snoring on more than three 
nights per week, and is present in 4.0-34.5% of children (Biggs, Nixon, & Horne, 2014b; Li et 
al., 2013). Habitual snoring in the absence of apnea, frequent arousals, or gas exchange 
abnormalities is diagnosed as primary snoring (Li et al., 2013). Primary snoring is on the mild 
end of the SDB spectrum, and historically, treatment has rarely been required (Biggs et al., 
2014b; Li et al., 2013).  
 With the advancement of research on childhood OSA, studies have found that children 
with primary snoring are at increased risk for neurodevelopmental and behavioural consequences 
such as hyperactivity, inattentive behaviour, and poor school performance (Brockmann, Urschitz, 
Schlaud, & Poets, 2012; Li et al., 2013). Thus, although the mechanism of action differs, the 
consequences of primary snoring are similar to those associated with OSA (Biggs et al., 2014b; 
Brockmann et al., 2012). In OSA, frequent arousals leading to sleep deprivation and intermittent 
hypoxia are proposed to be the source of behavioural consequences (Biggs et al., 2014b). 
However, frequent arousals and intermitted hypoxia do not exist in primary snoring; thus, the 
mechanism by which children with primary snoring exhibit behavioural issues is not known 
(Biggs et al., 2014b). Over one third of children with primary snoring will progress to OSA, 
especially in children who are obese or overweight (Li et al., 2013). Thus, primary snoring is not 
a stable condition. This places emphasis on screening children with primary snoring repeatedly 
over time, particularly children who are obese or overweight. The following section will discuss 
children who are at increased risk for developing OSA. 
Risk Factors 
 Risk factors of childhood OSA can be divided into common risk factors seen in otherwise 
healthy children, and risk factors which occur in children with complex health needs. The main 
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risk factors for childhood OSA in otherwise healthy children include adenotonsillar hypertrophy 
and obesity (DelRosso, 2016; Kang, Chou, Weng, Lee, & Hsu, 2013; Marcus et al., 2012). The 
literature cites numerous other conditions, including neuromuscular disorders, craniofacial 
disorders, and genetic syndromes that also increase the risk of children developing OSA 
(DelRosso, 2016; Marcus et al., 2012). However, children with the above mentioned conditions 
often have complex health needs and are followed by pediatric specialists, as such, screening for 
OSA in children with complex health needs is less likely to occur in the primary care setting. 
Appendix A lists additional conditions that increase the risk factor for developing OSA, but will 
not be discussed further. For the purpose of this integrative review, only the common risk factors 
for OSA in children without known comorbidities or complex health conditions will be 
discussed. 
 Adenotonsillar hypertrophy. Adenotonsillar hypertrophy, the enlargement of the 
adenoids and tonsils, is the most common risk factor for the development of OSA in children 
between the ages for two to eight years (DelRosso, 2016; Marcus et al., 2013; Tan et al., 2016; 
Villa et al., 2015). Enlarged tonsils and adenoids occupy a large portion of the oropharyngeal 
airway, resulting in upper airway narrowing and chronic nasal obstruction (Kang et al., 2013; 
Tan et al., 2016). During sleep, relaxation of the pharyngeal muscles further contributes to a 
reduction in the airway size, which increases the likelihood of upper airway obstruction during 
sleep, resulting in OSA (Kang et al., 2013).  
 Tonsil size can be classified by the Brodsky grading scale: grade I, small tonsils confined 
to the pillars; grade II, tonsils extend just outside the pillars; grade III, tonsils extended beyond 
the pillars but not to midline; and grade IV, tonsils that meet at midline (Kang et al., 2015). 
Tonsillar hypertrophy is often defined as tonsils at a grade III or above (Kang et al., 2015). 
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Adenoid size is more difficult to assess, as adenoids lie posterior to the nasal cavity and are not 
visible on physical exam. Assessment of adenoid size requires lateral radiographic imaging or 
flexible fiberoptic nasal endoscopy (Baldassari & Choi, 2013); thus is unlikely to be included in 
the initial assessment of a child with suspected OSA. Adenotonsillar hypertrophy increases OSA 
risk more than either adenoidal hypertrophy or tonsillar hypertrophy alone (Kang et al., 2013).  
 While children of all ages can be affected by adenotonsillar hypertrophy, children 
between the ages of two to eight years are at the highest risk for complications associated with 
adenotonsillar hypertrophy, as this age coincides with peak adenoid and tonsil growth 
(Bhattacharjee et al., 2011; DelRosso, 2016). However, not all children with enlarged tonsils and 
adenoids have OSA, and moreover, children whom have OSA may present without enlarged 
tonsils and adenoids (Dayyat, Kheirandish-Gozal, Capdevila, Maarafeya, & Gozal, 2009; Kang 
et al., 2013; Marcus et al., 2002). Thus, the relationship between adenotonsillar hypertrophy and 
OSA is imprecise (Dayyat et al., 2009; Marcus et al., 2002). Kang et al. (2013) discovered that 
tonsillar hypertrophy is more likely to be associated with OSA for children from ages 1-18 years, 
whereas, adenoid hypertrophy is only correlated with OSA in children between the ages 1-12 
years (Kang et al., 2013). Furthermore, while obesity and adenotonsillar hypertrophy 
independently are contributing factors to the development of childhood OSA, the extent of 
adenotonsillar hypertrophy required to cause airway obstruction is smaller in obese children, thus 
children with both obesity and adenotonsillar hypertrophy are at an even greater increased risk of 
developing OSA (Biggs, et al., 2014b; Dayyat et al., 2009; Tan et al., 2016). Tonsillar 
hypertrophy is more prevalent in the development of OSA for children aged 1-6 years, whereas 
obesity is more prevalent in children with OSA who are >6 years of age (Villa et al., 2015).  
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 OSA is well established as a significant morbidity associated with adenotonsillar 
hypertrophy; furthermore it is the primary indication for adenotonsillectomy (Marcus et al., 
2013). Despite this, adenotonsillectomy is not curative for all cases of OSA. A significant 
proportion of children treated with adenotonsillectomy continue to experience obstructive events 
during sleep post-operatively (Marcus et al., 2012; Tan et al., 2016).  Clinical practice guidelines 
suggest that clinicians reassess all children 6-8 weeks post adenotonsillectomy, and again at six 
and 12 months to determine if further treatment is needed (Kaditis et al., 2015; Marcus et al., 
2012). Obese children, and children with moderate to severe OSA prior to adenotonsillectomy 
have increased risk for residual OSA (Marcus et al., 2012; Marcus et al., 2013).  
 Obesity. The World Health Organization (WHO) cites that “childhood obesity is one of 
the most serious public health challenges of the 21st century,” and the prevalence of childhood 
obesity is increasing at alarming rates (WHO, 2016, para. 1). The Canadian Task Force on 
Preventive Health Care (2015) recommends that childhood obesity be diagnosed based on the 
2014 WHO Growth Charts for Canada (Canadian Paediatric Society, 2014). A child’s weight 
should be measured at all appropriate primary care visits, and children older than two years of 
age should have a body mass index (BMI) calculated, and plotted on the growth chart. Childhood 
obesity is defined as a BMI above the 99.9th percentile for 2-5 year olds, or above the 97th 
percentile for 5-19 year olds (Dietitians of Canada and Canadian Paediatric Society, 2014, p. 2).   
 Obesity is a major risk factor in the development of OSA. A study examining the 
prevalence of OSA in obese children recruited from a community setting, who were otherwise 
well is reported as between 21.5-39.5% (Alonso-Alverez et al., 2014). Thus, confirming that 
OSA is highly prevalent among otherwise healthy and asymptomatic obese children. Obesity is 
associated with both upper airway narrowing, and increased airway collapsibility (Dayyat et al., 
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2009; Kang et al., 2013; Kang et al., 2015). Furthermore, obesity and OSA have a cause and 
effect relationship; obesity is more prevalent in children with OSA, and children with OSA are at 
increased risk for obesity (Bhattacharjee et al., 2011). Physiologically, obese children have 
increased subcutaneous fat around the neck, which is associated with upper airway collapsibility, 
and which is further exacerbated when lying in the supine position (Blechner & Williamson, 
2016). Furthermore, fatty infiltrates of the upper airway tissues, such as the tonsils and tongue 
can result in narrowing of the upper airway (Blechner & Williamson, 2016; DelRosso, 2016). Fat 
disposition around the viscera, abdomen, and thoracic walls decrease lung tidal volumes and 
oxygen reserve, further compromising ventilation (Blechner & Williamson, 2016). Therefore, 
physical changes associated with obesity impact ventilation and in turn, impair sleep quality. 
Fragmented sleep from frequent arousals in OSA is associated with increased sympathetic 
nervous system activity and increased cortisol production, a metabolic disturbance that leads to 
obesity (Blechner & Williamson, 2016). Both obesity and OSA are associated with increased 
systemic inflammation as evidenced by increased serum inflammatory markers (Blechner & 
Williamson, 2016; Kheirandish-Gozal et al., 2015). Consequently, obesity and OSA are deeply 
intertwined, as both conditions pose as a risk factor and a consequence of the other.  
Pathophysiology  
 Obstructive sleep apnea is characterized by intermittent or prolonged, partial or complete 
upper airway obstruction during sleep (Marcus et al., 2012; Mukherjee et al., 2015). The 
recurrent airway obstructions are caused by anatomic narrowing or increased collapsibility of the 
upper airway (DelRosso, 2016; Tan et al., 2016). Airway patency depends upon a balance of 
outward (exhalation) and inward (inspiration) forces; normally the genioglosus muscle in the 
pharynx maintains airway patency during respiration. During normal rapid-eye movement 
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(REM) sleep, the genioglosus muscle relaxes, there is decreased ventilatory drive, and reduced 
intercostal activity; thus, mild airway narrowing during REM sleep is normal (DelRosso, 2016; 
Eckert & Malhotra, 2008). When coupled with additional factors that contribute to either upper 
airway narrowing or increased collapsibility, the likelihood of OSA occurring increases. Airway 
obstruction impairs ventilation resulting in hypoxemia and hypercapnia due to reduced gas 
exchange (Smith et al., 2016). The effects of hypoxemia and hypercapnia trigger a protective 
mechanism that leads to arousal from sleep to restore breathing (DelRosso, 2016). While arousal 
from sleep during a hypoxic event is essential to sustain life, it leads to fragmented, 
nonrestorative sleep, and cardiovascular, metabolic, neurocognitive, and behavioural 
consequences associated with chronic hypoxemia and sleep deprivation (Brockmann et al., 
2013b; Smith et al., 2016). The impact of untreated OSA is significant, and will be further 
discussion in the following section.   
Consequences of Untreated OSA 
 Untreated childhood OSA is associated with medical and behavioural concerns (Blechner 
& Williamson, 2016; Marcus et al., 2012; Tan et al., 2016). These consequences can 
significantly impact the quality of life for a child and their family, as well as create long-term 
developmental and social challenges for a child (Blechner & Williamson, 2016). The following 
section examines the metabolic, cardiovascular, and behavioural consequences associated with 
childhood OSA.  
 Metabolic. Metabolic syndrome is recognized as the compilation of obesity, 
dyslipidemia, hypertension, and impaired glucose tolerance/insulin resistance (Blechner & 
Williamson, 2016). Obesity is both a risk factor and consequence of childhood OSA. Obese 
children are known to have increased risk for conditions such as cardiovascular disease, 
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dyslipidemia, insulin resistance, type 2 diabetes, and OSA. Obese children with OSA also have 
metabolic concerns that are strongly associated with the effects of fragmented sleep and chronic 
hypoxemia, including increased activation of the sympathetic nervous system, release of excess 
cortisol, systemic inflammation, and insulin resistance (Blechner & Williamson, 2016). The 
consequences of childhood obesity and childhood OSA are intertwined and difficult to discern. 
However, Bhushan et al. (2014) determined that in obese children, there is a correlation between 
severity of OSA and insulin resistance. Furthermore, treating childhood OSA is associated with 
improved glycemic control (Bhushan et al., 2014). OSA and obesity are both associated with 
increase systemic inflammation, a risk factor for the development of dyslipidemia and heart 
disease. Treatment of OSA with adenotonsillectomy has proven to normalize inflammatory 
markers within six months following surgery, indicating that treating OSA and restoring normal 
nocturnal ventilation has positive effects on systemic inflammation (Kheirandish-Gozal et al., 
2015).  Therefore, while obesity and OSA have many overlapping comorbidities, both insulin 
resistance and systemic inflammation are independently associated with childhood OSA.   
 Cardiovascular. Obstructive sleep apnea is strongly associated with cardiovascular 
consequences in adults. Conversely, the link between OSA and cardiovascular disease in 
children is less clear (Blechner & Williamson, 2016). It has been hypothesized that any 
cardiovascular consequences associated with childhood OSA is linked to obesity, rather than 
associated with OSA (Blechner & Williamson, 2016; Chan et al., 2009). OSA is associated with 
repetitive activation of the sympathetic nervous system, which is associated with developing 
hypertension (Blechner & Williamson, 2016; Horne et al., 2011; Nisbet et al., 2013). Children 
with OSA have higher baseline blood pressure during REM sleep; REM-related hypertension is 
the first step towards daytime hypertension (Horne et al., 2011; Nisbet et al., 2013). Additionally, 
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school-aged children who snore have increased daytime hypertension when compared to non-
snoring children (Horne et al., 2011). Thus, there is a correlation between childhood OSA and 
hypertension. 
 Childhood OSA is also associated with physiological changes to the cardiac musculature 
(Chan et al., 2009). Both PSG and echocardiogram have been used to examine the presence of 
cardiac structural abnormalities and dysfunction in children aged 6-13 years of age with a 
diagnosis of OSA (Chan et al., 2009).  Findings identify OSA as a risk factor for the 
development of decreased right ventricular ejection fraction, left ventricular diastolic 
dysfunction, and cardiac remodelling with larger interventricular septal thickness index and 
relative wall thickness (Chan et al., 2009, p. 236). Treatment for OSA with either 
adenotonsillectomy or nasal corticosteroids found significant improvement in cardiac 
dysfunction over a six-month follow-up period (Chan et al., 2009). Consequently, OSA is an 
independent risk factor for cardiovascular disease in children, and treatment is associated with 
improved left and right ventricular dysfunction (Chan et al., 2009).  
 Behavioural. Behavioural issues are common among children with OSA, and untreated 
OSA has detrimental effects to neurocognitive development (Bonuck, Rao, & Xu, 2012; Smith et 
al., 2016). Neurocognitive deficits refer to impairments in neurologic and cognitive abilities, 
including attention, visual spatial skills, and working memory (Blechner & Williamson, 2016). 
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder affecting 3-
16% of school children, and is characterized by inattention, hyperactivity, and impulsivity, often 
leading to academic, social, and occupational dysfunction (Sedkey, Bennett, & Carvalho, 2014). 
ADHD is one of the most common disorders of childhood.  In recent years, there has been 
increased prevalence of ADHD diagnoses, and increasing trends towards the medical 
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management of the behavioural symptoms associated with ADHD (Visser et al., 2014). The 
relationship between OSA and ADHD is well established in the literature. Studies examining the 
effect of adenotonsillectomy on children with OSA and ADHD symptoms have shown reduction 
of ADHD symptoms, and improvement in behaviour and quality of life following surgery due to 
the resolution of OSA (Marcus et al., 2013; Sedky et al., 2014). Thus, treatment for OSA is 
associated with improved neurocognitive outcomes, supporting the link between childhood OSA 
and behavioural consequences.  
 Obstructive sleep apnea leads to fragmented sleep, which is also associated with 
neurocognitive consequences. Behaviour sleep problems, described as poor sleep hygiene 
resulting in bedtime refusal, difficulty sleeping, early waking, or frequent waking throughout the 
night in children over 18 months of age are associated with insufficient and fragmented sleep 
(Bonuck et al., 2012). A longitudinal study evaluating children with behavioural sleep problems 
or OSA found that children who suffered from fragmented sleep during the first five years of life 
had a 38% increase in special education needs at eight years of age (Bonuck et al., 2012). This 
places great emphasis on primary care providers educating families about the importance of 
sleep hygiene, as well as screening for OSA, as adequate sleep during early childhood improves 
educational outcomes.  
 The medical and neurocognitive consequences of untreated OSA can significantly affect 
childhood development as well as quality of life. Early recognition is key to minimizing the 
sequelae associated with childhood OSA. The next section will discuss the complexities of 





 Health screening identifies individuals who are at increased risk for disease, and require 
further investigation (Morabia & Zhang, 2004). The main goal of health screening is early 
recognition of disease to allow for prompt treatment, and reduced associated morbidity (Morabia 
& Zhang, 2004). Screening tests are not designed to be diagnostic, thus, screening is only 
considered beneficial if the screening test has: 1) good validity, 2) acceptable sensitivity, and 3) 
if early recognition of disease improves prognosis (Morabia & Zhang, 2004). The validity of 
screening tests is assessed based on the sensitivity and specificity, ideally benchmarked against 
the gold standard test for diagnosis (Maxim, Niebo, & Utell, 2014). Sensitivity refers to the 
screening tools ability to correctly identify an individual with the disease as positive (Maxim et 
al., 2014). Specificity refers to the screening tools ability to correctly identify an individual 
without the disease as negative, thus minimizing false positives (Maxim et al., 2014). Highly 
sensitivity screening tools minimize false negatives and ensure all individuals with the disease 
are recognized. A screening test with low sensitivity places individuals at risk of delayed 
recognition, and thus missing the benefit of early treatment. When screening is performed in the 
primary care setting, the ideal screening tool is inexpensive, non-invasive, and highly sensitive 
(Maxim et al., 2014).  
 Health screening is a key aspect of preventative health care, especially during early 
childhood. In BC, there are well-established health care screening programs for early recognition 
of dental, hearing, and vision concerns (Government of British Columbia, n.d.). Newborn 
Screening is an example of a well-established program in BC that allows for the early detection 
of 22 disorders that could result in long-term disability if unrecognized (Government of British 
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Columbia, n.d.). The following section will discuss the screening recommendations for 
childhood OSA, as well as the barriers to screening in the primary care setting.  
 Screening recommendations. As untreated OSA has significant consequences for 
children, screening for OSA is indicated in the primary care setting. Clinical practice guidelines 
and child health records can help guide primary care providers follow childhood OSA screening 
recommendations.  
 Clinical practice guidelines. The AAP Clinical Practice Guidelines for the Diagnosis and 
Management of Childhood Obstructive Sleep Apnea Syndrome were revised in 2012 to reflect 
the advancement of research and increasing significance placed on early recognition of 
childhood OSA (Marcus et al., 2012). The AAP guidelines recommend that primary care 
providers inquire about the presence of snoring at all routine health maintenance visits for 
children over one year of age as a universal screen for all children (Marcus et al., 2012). If a 
child snores on a regular basis, it is recommended that they be referred for PSG. If PSG is not 
available, then referral to a pediatric sleep specialist or otolaryngologist is recommended 
(Marcus et al., 2012). The AAP guidelines also recommend that clinicians re-evaluate all 
children 6-8 weeks following treatment for OSA, including adenotonsillectomy, to determine if 
further treatment is required (Marcus et al., 2012). 
 Additional documents that provide evidence based recommendations towards screening 
for childhood OSA include the European Respiratory Task Force Obstructive Sleep Disordered 
Breathing in 2- to 18-year old Children: Diagnosis and Management (Kaditis et al., 2015), and 
the American Academy of Sleep Medicine (AASM) Quality Measures for the Care of Pediatric 
Patients with Obstructive Sleep Apnea (Kothare et al., 2015). Expectedly, the indications for 
screening for OSA in both documents mirror the recommendations in the 2012 AAP guidelines. 
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An additional similarity is the recognition of signs and symptoms of childhood OSA that should 
prompt screening. Table 1 lists common signs and symptoms in patients with OSA as described 
by Kaditis et al. (2015), Kothare et al. (2015), and Marcus et al. (2012).  
 The above clinical practice guidelines outline three indications for childhood OSA 
screening in the primary care setting: 1) during all routine health maintenance visits, as a 
universal screen; 2) when any signs or symptoms of childhood OSA are identified (see Table 1), 
as population specific screening; and 3) after adenotonsillectomy. 
Table 1 
Signs and Symptoms of Childhood OSA 
History Physical Exam 
• Frequent snoring (≥ 3 nights/week) 
• Labored breathing during sleep 
• Gasps/snorting noises/observed episodes 
of apnea 
• Sleep enuresis (especially secondary 
enuresis) 
• Sleeping in a seated position or with the 
neck hyperextended 
• Cyanosis 
• Headaches on awakening 
• Daytime sleepiness 
• Attention deﬁcit hyperactivity disorder 
• Learning problems 
• Prematurity of family history of SDB 
• Underweight or overweight 
• Tonsillar hypertrophy 
• Adenoidal facies 
• Micrognathia/retrognathia 
• High-arched palate 
• Failure to thrive 
• Hypertension 
Note. Adapted from Kaditis et al., 2015; Kothare et al., 2015; Marcus et al., 2012. 
 Child health records used in primary care. Child health and development tools, 
including the Rourke Baby Records (RBR) and the Greig Health Record are guides that are 
commonly used by primary care providers in BC to prompt appropriate history, physical 
examination, developmental milestones, and anticipatory guidance based on a child’s age during 
health maintenance visits (Greig et al., 2016; Rourke, Leduc, & Rourke, 2014). Both tools are 
 18 
endorsed by the Canadian Paediatric Society, and provide recommendations on OSA screening 
in the primary care setting.  
 The Rourke Baby Record (RBR) is an evidence-based health supervision guide utilized 
by primary care providers in Canada for children from one week to five years of age. The RBR 
provides growth and nutrition monitoring, developmental surveillance, physical examination 
parameters, immunizations, and anticipatory guidance on safety, family, behaviour and health 
promotion issues for well-baby and well-child visits (Rourke et al., 2014). After the first year of 
life, the RBR recommends well-child visits at ages 12 month, 18months, and then annually until 
five years of age (Rourke et al., 2014). The RBR recommends screening for tonsil size and OSA 
during all well-child visits starting at the age of 12-13 months (Rourke et al., 2014). However, if 
OSA concerns are identified during a well-child visit, practitioners are directed to the AAP 
Clinical Practice Guidelines from 2002, which takes a more conservative approach than the more 
recent 2012 guidelines (American Academy of Pediatrics, 2002; Rourke et al., 2014).  
 The Greig Health Record is an evidence-based health promotion guide aimed towards 
primary care providers in Canada caring for children and adolescents aged six to 17 years of age 
(Greig et al., 2016). The Greig Health Record recommends that children attend well-child visits 
every one to two years between the ages of 6-18 years, and prompts primary care providers to 
provide anticipatory guidance regarding sleep issues with patients, and their parents. Sleep 
recommendations focus on sleep hygiene, the recommended hours of sleep for each age group, 
as well as OSA risk factors and consequences (Greig et al., 2016).  
 Both the RBR and Greig Health Records have intuitive templates that prompt primary 
care providers to discuss age-appropriate preventative health care topics. Furthermore, both 
health records are easily embedded into electronic medical records (EMR), which allow for easy 
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documentation of prevention and screening topics that have been discussed during health 
maintenance visits. Evidently, there are multiple guidelines and resources primary care providers 
can access that provide recommendations for screening for childhood OSA. The following 
section will describe the primary barriers to screening implementation in the primary care 
setting.  
 Barriers to screening. Screening for childhood OSA ideally occurs in the primary care 
setting during routine maintenance visits. Unfortunately, there are multiple barriers to screening 
in primary care. Missed opportunities for screening during primary care visits have been 
identified as a barrier to OSA screening, primarily due to a lack of primary care provider 
education on the importance of screening for childhood OSA, and secondly due to poor 
attendance of routine health maintenance visits. The following section will discuss these barriers 
to childhood OSA screening. 
 Missed opportunity during primary care visits. The AAP clinical practice guidelines 
recommend that children be screened for OSA at each health maintenance visit, as evidence-
based knowledge shows that early recognition results in “alleviation of current symptoms, 
improved quality of life, prevention of sequelae, education of parents, and decreased health care 
utilization” (Marcus et al., 2012, p. 578). However, a study by Erichson et al. (2012) verifies that 
children are not being adequately screened for SDB in the primary care setting, and the AAP 
guidelines are not being followed. A cross-sectional study of 1032 manually reviewed electronic 
charts by Erichson et al. (2012) confirmed that primary care practices caring for children are 
“highly unlikely to screen for OSA,” as only 25% of children who presented for a routine health 
maintenance visit were assessed for snoring (p. 1126). Reasons for poor screening for snoring in 
the primary care setting included time constraints on primary care providers, and the belief that 
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parents would volunteer information if they had any concerns regarding their child’s sleep 
(Erichson et al., 2012; Faruqui et al., 2011). However, when asked about OSA symptoms in the 
primary care setting, the “presence of snoring was underestimated by approximately 20%” of 
caregivers further contributing to poor recognition and delayed diagnosis of childhood OSA 
(Alonso-Alverez et al., 2014, p. 948). Additionally, there is a lack of awareness and knowledge 
regarding pediatric sleep disorders among trained primary care providers, thus, it can be 
postulated that parents and caregivers also lack awareness of the signs and symptoms of OSA 
(Erichson et al., 2012; Mindell et al., 2013). Therefore, parents and caregivers cannot be 
expected to bring forth OSA concerns without prompting and education of signs and symptoms. 
 Lack of primary care provider education. A lack of training at all levels of medical 
school and residency programs is a significant barrier to adequate screening for SDB in primary 
care settings (Erichson et al., 2012). A survey study of 346 pediatricians by Faruqui et al. (2011) 
discovered that only 18% of pediatricians report receiving formal education on pediatric sleep 
disorders, and only 13% were able to correctly answer questions regarding OSA. A questionnaire 
based survey study of 152 directors of pediatric residency programs across 10 countries 
determined that the median amount of time spent on sleep related education was two hours 
(Mindell et al., 2013). In 2005, Shepard et al. acknowledged that the domain of sleep medicine 
had only recently been recognized as a speciality of medicine. Furthermore, Tan et al. (2016) 
note that there has been significant interest in the research of pediatric sleep medicine in the past 
several years, resulting in changes to the knowledge, and clinical evaluation of childhood OSA. 
Yet, pediatric sleep medicine is still not recognized as its own medical discipline in Canada, and 
consequently, there is a lack of specialized pediatric sleep services nationwide (Ipsiroglu, 2008; 
Katz et al., 2014). Thus, the literature identifies lack of primary care provider education and 
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knowledge as a significant barrier to implementing pediatric OSA screening strategies in the 
primary care setting (Erichson et al., 2012; Faruqui et al., 2011). 
 Lack of child health maintenance visits. Another significant barrier to screening for 
OSA in the primary care setting is poor attendance of child health maintenance visits, 
particularly between the final infant immunization at 18 months and the start of kindergarten. 
The RBR and Greig Health Record outline a schedule of recommended well-child health 
maintenance visits, which after the first year of life should occur at 18-months, two years old, 
and then annually to the age of six, at which time they are recommended every 1-2 years (Greig 
et al., 2016; Rourke et al., 2014). A Toronto based study found that the rates of 18-month well-
baby visits were between 25.6% to 66.1%, and higher income areas were associated with higher 
rates of well-baby visits (Toronto Public Health, 2016). A report focusing on Northern BC, 
found that children from rural and remote communities have inferior health than children living 
in urban areas, postulated to be due to poor access to health care services and preventative health 
screening (Allison, 2016). Thus, if children do not present for routine health maintenance visits, 
they do not have the opportunity to be screened for OSA. Poor attendance of health maintenance 
visits could be due to both lack of parental education regarding the importance of well child 
visits, and the lack of access to primary care services in rural and remote communities. An 
additional factor is the illness-centric model of health care that does not place importance on 
preventative child health visits. Child health maintenance visits require a trusting relationship 
between a consistent primary care provider and the family. Families need to be educated 
regarding the importance of regular preventative health care visits, in order to achieve the 
frequency of visits outlined by the RBR and Greig Health Records. The primary health care 
model has a strong presence in primary care, and places importance on health promotion and 
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preventative health care (Canadian Nurses Association, 2015). Furthermore, primary health care 
encourages patients as partners in their care and values community-based care that improve 
patients’ access to care (Canadian Nurses Association, 2015).  Thus, effective screening for 
childhood OSA requires a primary care provider that values the important role of health 
promotion and preventative health care in the primary care setting.  
 As reviewed, there are multiple sources that primary care providers can access to guide 
the screening of childhood OSA. Unfortunately, the lack of OSA screening in the primary care 
setting is multifactorial. While screening guidelines for childhood OSA in the primary care 
setting are limited by poor uptake, the role of diagnostics also comes with additional complex 
challenges. This will be discussed in the next section.  
Diagnostic Approach 
 Childhood OSA is strongly suspected based on the recognition of persistent snoring in 
addition to identified risk factors and signs and symptoms (Table 1); however, diagnosis requires 
polysomnography (PSG). In this section, PSG and the barriers to accessing this resource will be 
reviewed.  
 Polysomnography. Polysomnography (PSG) is the gold standard for diagnosing OSA 
(Alverez et al., 2015; Marcus et al., 2012; Villa et al., 2015). As history and clinical evaluation 
alone have poor sensitivity and specificity towards a diagnosis of pediatric OSA, PSG is required 
to establish a diagnosis and determine the severity of disease (Villa et al., 2015). PSG is the only 
tool recognized to differentiate primary snoring from OSA in children (Brockmann et al., 2012). 
PSG is a level 1-sleep study, which occurs in a sleep laboratory, with a technician in attendance 
throughout the study (Blackman et al., 2010). PSG records oxygen saturations, heart rate, 
respiratory rate, brain waves, as well as eye and leg movements, which provide metrics of sleep 
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to diagnosis ventilation and sleep abnormalities associated with OSA (Garde et al., 2014). PSG 
quantifies OSA utilizing the apnea/hypopnea index (AHI), which is defined as the number of 
apnea and hypopnea events per hour of sleep (Alonso-Alvarez et al., 2014). While criteria for 
classification of OSA varies among different guidelines, generally, an AHI <5 events/hour is 
mild, AHI ≥ 5 and < 10 events/hour is moderate, and an AHI ≥10 events/hour is severe (Alonso-
Alvarez et al., 2014). Many published studies use the AHI cut-off of ≥1 event/hour to define 
OSA, whereas treatment for OSA is often indicated for AHI ≥ 5 events/hour (Garde et al., 2014; 
Kaditis et al., 2015). A relationship exists between the severity of OSA, as determined by the 
surrogate marker AHI, and the extent to which a child is negatively affected by OSA. A study by 
Kheirandish-Gozal, De Jong, Spruyt, Chamuleau, and Gozal (2010) found a negative correlation 
between AHI severity and cognitive ability; higher AHI values were associated with greater 
cognitive deficits. Conversely, a randomized controlled trial by Marcus et al. (2013) that 
compared the effects of adenotonsillectomy versus watchful waiting in children with mild OSA, 
did not find clinically significant improvements in cognitive function in children who were 
randomized to the adenotonsillectomy group, although there were improvements in secondary 
outcomes such as behaviour and quality of life. The result of this study is postulated to reflect the 
ethical requirements of the recruitment strategy to only allow children with mild OSA to 
participate (Marcus et al., 2013). Thus, while an AHI ≥1 event/hour is diagnostic of OSA, AHI 
of >3-5 events/hour provide a greater risk-benefit ratio when determining when to treat OSA.  
 Barriers to diagnostics. For children in BC, PSG is only available in a sleep laboratory 
situated in the BC Children’s Hospital (BCCH) in Vancouver. As such, there are many 
limitations to PSG: it requires hospitalization; it is stressful to children and parents; it is not 
widely available; and it is expensive (Brockmann, Perez, & Moya, 2013a). Logistics of traveling 
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to Vancouver can be a significant barrier for many families from rural and Northern BC. 
Additionally, BCCH only has the capability of performing 250 sleep studies each year, resulting 
in a six-month waiting list for pediatric PSG (Garde et al., 2014). Throughout Canada there is a 
significant lack of PSG services, especially for pediatric patients (Katz et al., 2014). A study of 
pediatric PSG resources by Katz et al. (2014) found that there are approximately 9,185 pediatric 
PSG studies performed each year in Canada. However, based on the Canadian general pediatric 
population of 6,923,899, and assuming the lowest prevalence of OSA at 1%, there are at 
minimum 69,239 children in Canada with OSA.  Therefore, within Canada there are 7.5 times 
more children with suspected OSA than diagnostic testing capability (Katz et al., 2014).  
 An additional barrier surrounding the diagnosis of OSA is the issue of prescribing PSG. 
In BC, primary care providers are not able to refer children directly for PSG, therefore, they must 
first be referred to a specialist; either a pediatric otolaryngologist or respirologist (BC Children’s 
Hospital, 2017b). Accordingly, the total wait time to receive a PSG sleep study to diagnose OSA 
is dictated by the wait time to see the specialist, in addition to the wait time for PSG. From when 
OSA is first suspected to when PSG can be performed, wait time estimate is up to a year, 
resulting in suboptimal investigation delay and subsequent management. 
 While PSG is the gold standard for investigation for OSA, other tests are available but 
not applicable to children. There are four levels of sleep studies utilized to assess for OSA (see 
Table 2). In adults with suspected OSA, primary care providers can order a level 3 sleep study. A 
level 3 sleep study is unattended “portable monitoring with three or more channels including 
pulse oximetry and heart rate”, which is conducted in a patients’ own home and set up by a 
trained technician associated with an accredited sleep medicine clinic (Blackman et al., 2010, p. 
230). While level 3 sleep studies are not the gold standard for diagnosing OSA, it can expedite 
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treatment, or triage patients to receive level 1 PSG sleep studies earlier. Thus, they can receive 
treatment for OSA earlier, limiting the consequences and sequelae associated with untreated 
OSA. While home sleep studies are readily available in many BC communities for adults, 
primary care providers do not have the opportunity to order home sleep studies as a screening 
tool for children with suspected OSA due to a lack of clinical practice guidelines and 
recommendations.  
Table 2 
Levels of Sleep Studies Used to Evaluate OSA  
Levels of Sleep Studies 
Level 1 In-laboratory, technologist attended, polysomnography 
 
Level 2 Full (unattended) polysomnography 
 
Level 3 Portable monitoring with three or more channels, including pulse oximetry and 
heart rate 
Level 4  Portable monitoring with only one or two channels including pulse oximetry 
 
Note. Adapted from Blackman et al., 2010. 
 As highlighted, primary care providers, including NPs have an important role in 
screening for childhood OSA. The following chapter will discuss the comprehensive search 
strategy used to obtain relevant literature to help answer the question: what strategies can NPs, as 
primary care providers, implement to improve screening for OSA in children between the ages of 




CHAPTER THREE  
 
Methods  
 An integrative review is a method of presenting a comprehensive understanding of 
literature, which can influence theory development, inform evidence-based practice, and have a 
direct applicability to nursing practice and policy (Souza, Silva, & Carvalho, 2010; Whittemore 
& Knafl, 2005). Conducting a focused and thorough literature search is necessary to collect 
relevant data that can be analyzed and synthesized towards an integrative review. Searching the 
literature in a systematic way helps to enhance rigor and ensure searches can be reproduced to 
find new and innovative literature and studies (Whittemore & Knafl, 2005). Following the 
integrative review approach outlined by Souza et al. (2010) and Whittemore and Knafl (2005) a 
comprehensive and systematic literature search was performed to address the research question: 
what strategies can NPs, as primary care providers, implement to improve screening for OSA in 
children between the ages of 2-8 years to determine need for referral? The search strategy, 
including the preliminary search, eligibility criteria, and the focused search of the literature will 
be discussed.  
Preliminary Search 
 The literature search was conducted on four electronic databases through the University 
of Northern British Columbia library: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) complete, National Library of Medicine (PubMed), Medline (Ovid), and Cochrane 
Database of Systematic Reviews (CDSR) between the dates of 2011 and 2017.  
 MeSH headings and the use of Boolean search language of AND, OR, and * to truncate 
words were used when appropriate. Table 3 provides the search terms used for this literature 
search.  
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Table 3  
Search Terms 
 
 The searches conducted using the terms ‘nurse practitioners’ and ‘primary health care’, 
and ‘primary care’ evidently narrowed the search and excluded many relevant articles. 
Therefore, selecting articles that are pertinent to the primary care setting, and NPs as primary 
care providers became an inclusion criterion, rather than a search term used during the 
preliminary search. Appendix B presents the results from each search term, and combination of 
search terms used during this preliminary search.  
 Grey literature on pediatric obstructive sleep apnea was searched to retrieve clinical 
guidelines, policies, and reports from the Canadian Thoracic Society, Canadian Sleep Society, 
American Academy of Sleep Medicine, Academy of Otolaryngology Head and Neck Surgery 
Foundation, American Academy of Paediatrics, Canadian Pediatric Society, and BC Children’s 
Hospital. Hand searches from reference lists of key articles were conducted to ensure all relevant 
articles were identified. Lastly, through reading a vast assortment of publications on childhood 
OSA, authors whom are leaders in the research, publication, and advancement of pediatric sleep 
medicine were identified. Alerts were set through ResearchGate and CINAHL to ensure new 
Search Terms 
 
pediatric*, paediatric, child*, pediatrics (MeSH) 
 
sleep apnea, obstructive sleep apnea, OSA, sleep disordered breathing, SDB, sleep apnea, 
obstructive (MeSH) 
 
screen*, screening tool, clinical assessment tools 
 
primary care, primary health care (MeSH) 
 
nurse practitioner*, nurse practitioners (MesH) 
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publications from these leading authors would be identified, as their publications were 
anticipated to be highly relevant to this topic.  
Eligibility 
 The next step towards the search strategy was narrowing the number of articles to be 
reviewed based on a set of inclusion and exclusion criteria. The focus of the research question 
was inclusive to children between the ages of 2-8 years old, without complex health conditions 
that predispose them to OSA. Inclusion and exclusion criteria were also needed to ensure the 
screening strategies could be utilized in the primary care setting, and by family practice primary 
care providers, including NPs. This would effectively eliminate articles that were aimed towards 
physicians with advanced knowledge and skills regarding pediatric sleep medicine, 
otolaryngology, or respirology. It was important to eliminate studies that reviewed screening 
strategies that required a hospital setting or sleep laboratory, as they could not be reproduced in 
the primary care setting. Searches were limited to peer-reviewed studies and publication years 
from 2011 to 2017. Pediatric sleep medicine is a new subspecialty of medicine, and there have 
been significant advancements in the research of pediatric sleep medicine in the past several 
years (Shepard et al., 2005; Tan et al., 2016). This places emphasis on the need for recent 
















Children between the ages 2-8 years Infants, adolescents, adults 
Screening strategies that can be used in the 
primary care setting by primary care providers 
(NPs and general practitioners or family 
physicians ) 
 
Screening tools that require a hospital 
setting, specialized sleep laboratory, or 
advanced/specialized training. For example, 
polysomnography technicians, 
respirologists, sleep medicine specialists, 
otolaryngologist, and anesthesiologists  
 
Children with common risk factors for OSA 
(adenotonsillar hypertrophy and obesity)  
Children with comorbidities or complex 
medical conditions that predispose them to 
obstructive sleep apnea (see Appendix A) 
 
Focus on screening for childhood OSA Focus on pharmacological management, 
surgical management, or BiPAP/CPAP 
treatment options 
 
Published between 2011 to 2017, to reflect 
current practice, and the advancements in 
research  
 
Publications prior to 2011 
 
Full text papers and articles including original 
quantitative or qualitative studies, systematic 
reviews, and meta-analyses  
 
Discussion papers, literature reviews, non-
peer reviewed publications, newspaper or 
magazine editorials, and opinion pieces  
Publications in English Publications in any language aside from 
English 
 
Focused Search and Analysis Approach 
 All retrieved articles were exported into a citation manager, duplicates were eliminated, 
and the titles and abstracts were screened for eligibility based on the predetermined inclusion and 
exclusion criteria. The remaining literature was further screened by a full review of the article. 
Articles that did not meet the inclusion/exclusion criteria were eliminated. Using the Critical 
Appraisal Skills Programme (CASP) tools (CASP, 2017a), each article was individually 
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appraised to assess the strengths, limitation, and validity of study design and findings. Two 
CASP checklists were utilized during the analysis of literature phase, and are included in 
Appendix C. The CASP tools checklist considers the following three broad issues during 
appraisal: 1) “are the results of the study valid;” 2) “what are the results;” and 3) “will the results 
help locally” (CASP, 2017a, para 1). Upon thorough review of the literature, 11 articles were 
identified as high quality and valuable to help answer the research question: what strategies can 
NPs, as primary care providers, implement to improve screening for OSA in children between 
the ages of 2-8 years to determine need for referral? Figure 1 illustrates the full search strategy. 
The 11 selected articles were then analyzed based on their application in the primary care setting, 
which helped to create three distinct themes. The following chapter will present an analysis of 




















 The aim of this integrative review was to answer the question: what strategies can NPs, as 
primary care providers, implement to improve screening for OSA in children between the ages of 
2-8 years to determine need for referral?  Guided by this research question, a systematic 
literature search was conducted, and a final cohort of 11 articles was identified. Through critical 
analysis of the literature, as outlined in the previous chapter, three major themes to improve 
childhood OSA screening emerged: 1) use of validated pediatric OSA screening questionnaires; 
2) use of subjective and objective variable screening tools; 3) the feasibility of home-based 
nocturnal oximetry for children with suspected OSA. Ten of the final selected articles are 
original quantitative research studies, and one is a systematic review. Analysis of these studies 
will now be presented.  
Use of Validated Pediatric OSA Screening Questionnaires 
 Clinical practice guidelines recommend the following three indications for routine and 
episodic screening children for OSA: 1) at all well child visits; 2) when any risk factors are 
identified (see Table 1); and 3) after adenotonsillectomy (Kaditis et al., 2015; Kothare et al., 
2015; Marcus et al., 2012). However, aside from asking about snoring, guidelines do not 
recommend a specific tool to assist with screening. Numerous questionnaire based screening 
tools for pediatric OSA exist, with varying sensitivity and specificity when compared to the gold 
standard of PSG. This section will analyze questionnaire based screening tools that can be used 
by primary care NPs in the clinic based setting to screen for childhood OSA. The first article is a 
systematic review that delineated the diagnostic accuracy of specific indicator of childhood OSA 
within a questionnaire based screening tool, and the following four articles are quantitative 
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studies evaluating questionnaire based screening tools that can be easily administered in the 
primary care setting.  
 The first article analyzed was a systematic review by Certal et al. (2012) comparing 
clinical signs and symptoms of pediatric OSA to PSG findings. The researchers completed a 
meta-analysis to determine the diagnostic accuracy of individual and combined clinical signs and 
symptoms in predicting pediatric OSA. Two researchers conducted the systematic review across 
four medical databases (from start data records to August 2011) with ten studies between 1992-
2006 selected for the meta-analysis (Certal at al., 2012). Inclusion criteria required all studies use 
PSG metrics and clinical evaluation in order to determine the correlation of signs and symptoms 
of childhood OSA with PSG findings (Certal et al., 2012). Diagnostic 2x2 contingency tables 
were constructed to determine the sensitivity, specificity, true positive, false negative, false 
positive, and true negatives of each clinical sign and symptom, using an AHI >1 events/hour as 
diagnostic for childhood OSA. Five clinical signs and symptoms with the greatest accuracy for 
predicting childhood OSA were identified as: snoring, excessive daytime somnolence, tonsillar 
size, difficulty breathing during sleep, and observed apnea (Certal at al., 2012). There was a wide 
distribution of sensitivity and specificity of each of the clinical signs and symptoms of pediatric 
OSA (see Table 5). However, overall, this review found that snoring and tonsil size had high 
sensitivity, but low specificity (Certal et al., 2012). Whereas, excessive daytime somnolence, 
difficulty breathing during sleep, and observed apnea had high specificity but low sensitivity for 






Diagnostic accuracy of clinical signs and symptoms of pediatric OSA  
Note. Adapted from Certal at al., 2012. 
 The strengths of this systematic review were the clear explanation of methodology, and 
well-defined search terms and selection criteria. Furthermore, it provided strength and validity to 
the clinical signs of and symptoms of pediatric OSA by pooling data from multiple sources. A 
limitation of this review was a lack of clarity of the ages of children in each of the included 
studies, as well as no explication of exclusion criteria such as craniofacial or neurologic 
abnormalities. This minimized the external validity in relation to otherwise health children 
between the ages of 2-8 years. Furthermore, while this systematic review was reported in 2012, 
the studies included were from prior to 2011. This limited the applicability of the review, due to 
the shift in practice recommendations occurring with the revision of the AAP clinical practice 
guidelines in 2012. There have been significant advances in pediatric OSA research in the past 
five years, as well as improved recognition of the behavioural and neurocognitive consequences 
of untreated OSA. Therefore, a more recent systematic review and meta-analysis may discover 
the significance of additional clinical signs and symptoms of pediatric OSA, such as 
















































 Unfortunately, this study determined that individual and combined clinical signs and 
symptoms of OSA do not have satisfactory diagnostic accuracy in predicting pediatric OSA, 
further emphasizing the need for better screening tools and access to PSG.  However, by 
providing the sensitivity and specificity data for common variables associated with pediatric 
OSA, this study provides important information to answer the research question for this 
integrative review. Establishing clinical indictors with higher diagnostic accuracy are useful for 
primary care providers related to the decision making regarding which children require referral 
for suspected OSA.  
 The next study analyzed was a highly cited randomized community-based cohort study 
by Spruyt and Gozal (2012). This study aimed to delineate which subjective questions in a 
questionnaire-based intervention are useful to identify children with SDB, thus, detecting 
children at risk for OSA. Parents of 1,133 children between the ages of 5-9 years old completed a 
comprehensive 37-item Likert scale sleep-related questionnaire. Children were then randomly 
selected to undergo PSG (n=667); there were no significant socioeconomic differences between 
the 667 children who underwent PSG and those that did not (Spruyt & Gozal, 2012). Each sleep-
related question was analyzed using factor analysis to test reliability and internal consistency, 
and Mokken Scale Analysis to determine scalability in order to create a hierarchy of questions 
(Spruyt & Gozal, 2012). Spruyt and Gozal (2012) also employed common apnea-hypopnea index 
(AHI) cut-off criteria to determine the statistical association between the Likert scale scoring of 
each question and OSA events. The researchers found that six questions scored on severity had 
the greatest correlation with OSA with an AHI >3 events/hour. A score of >2.72 on the severity 
hierarchy resulted in a sensitivity of 59.03% and specificity of 82.85% (Spruyt & Gozal, 2012). 
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Thus, this study provided a list of subjective questions to streamline the process of screening 
children whom are high risk for OSA.  
 The strengths of this study included the large sample size and identification of 
appropriate exclusion criteria. The study compared the sample with the gold standard diagnosing 
approach for OSA, PSG, which was essential for ensuring internal validity. The study described 
the results and analysis of the data collection using clearly presented tables, which improved 
readability and allowed easy interpretation of the data for the reader. However, the study did 
have limitations, primarily the use of a parent-completed questionnaire; questionnaire based 
studies can result in bias or inaccuracies due to the subjective nature of the topic. Nonresponse 
bias is another concern with questionnaire-based studies, as the sample population within the 
study may not represent the actual target population of interest. The researchers also did not 
describe how they achieved randomization, placing the methodology at risk of bias. This study 
was based on 5-9 year old children, recruited from the school setting, and applied exclusion 
criteria of syndromes or conditions that predispose children to developing OSA; thus, the sample 
population studied was very similar to the population in the research question. This study is 
useful in addressing the research question, as it validates an uncomplicated and convenient six-
item questionnaire that can easily be used by NPs in the primary care setting to improve the 








Hierarchically arranged questions to aid the screening of children at high risk of OSA. 
Set of six hierarchically arranged questions 
1. Do you ever shake your child to make him/her breathe again when asleep? 
2. Does your child ever stop breathing during sleep? 
3. Does your child struggle to breathe while asleep? 
4. Are you ever concerned about your child’s breathing during sleep? 
5. How loud is the snore? 
6. How often does your child snore? 
Note. Adapted from Spruyt & Gozal, 2012. 
 In the next study, Kadmon, Chung, and Shapiro (2014) developed and validated an 8-
item screening tool—I’M SLEEPY—that can be used in the primary care setting for suspected 
childhood OSA. The screening tool, with the easy to remember mnemonic I’M SLEEPY can be 
found on Table 7. The researchers also tested other versions of the I’M SLEEPY screening tool, 
including IF SLEEPY (F for fidgeting/hyperactivity), I SLEEPY, and a modified STOP-BANG 
(validated screening tool for adults, with elimination of the sixth question regarding age>50). 
The screening tools were validated in a study of 150 children between the ages of 3-18 years 
(mean age 11 years) who were referred to a pediatric sleep clinic in Toronto, Ontario (Kadmon et 
al., 2014). Parents completed the yes/no questionnaires for children under the age of seven years, 
and children seven years and older completed a pediatric version of the same questionnaire. Each 
child underwent PSG, and the staff performing, scoring, and reviewing the PSG data were 
blinded to the score on the questionnaire. The study found that a score of ≥3 out of the eight I’M 
SLEEPY screening questions was found to have 82% sensitivity and 50% specificity for the 
diagnosis of OSA in children for the parent completed version (Kadmon et al., 2014). The same 
I’M SLEEPY questionnaire, when completed by the child (>7 years of age) has 47% sensitivity 
and 58% specificity (Kadmon et al., 2014). The IF SLEEPY had a sensitivity of 45% and 
specificity of 52%; the I SLEEPY had a 76% sensitivity and 55% specificity; and the modified 
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STOP-BANG which was only completed for children 7-18 years of age had a 12% sensitivity 
and 90% specificity (Kadmon et al., 2014). Thus, of all the tools evaluated in this study, the I’M 
SLEEPY provides the greatest validity as a screening tool for childhood OSA.  
 A significant strength of this study is the validity achieved with the simplicity of the 
screening tool developed. Furthermore, the I’M SLEEPY mnemonic is easy to remember, and 
the screening tool is simple to administer and score in the primary care setting. Study methods 
were clearly described, and the AHI cut-offs for OSA, were clearly identified (mild OSA defined 
as AHI ≥1.5 and <5 events/hour; moderate as ≥5 and <10 events/hour; severe as AHI ≥10 
events/hour), which allowed this study to be reproduced with the same endpoints. However, 
there are limitations to this study that reduce the external validity to the population in the 
research question. Firstly, the researchers only recruited children who were referred to a pediatric 
sleep clinic, resulting in sample bias, thus the tool would need to be further validated among 
children in a community or primary care setting. Furthermore, the age range within the study of 
3-18 years was very broad and reduced the external validity to population identified in the 
research question. Overall, the I’M SLEEPY screening tool, when completed by the parent, had 
good sensitivity, but only moderate specificity. Since the child completed version of the I’M 
SLEEPY screening tool had poor validity, a limitation of this study is that it is unknown if the 
screening tool has poor validity for children >7 years of age, or if the child-completed 
questionnaire result in inaccuracy of data collection. However, as childhood OSA often goes 
unrecognized, the I’M SLEEPY screening tool has important utility in the screening process, as 
it can improve awareness of clinical signs and symptoms of OSA and help trigger important 




I’M SLEEPY questionnaire 
Parent version 
I  – is your child often Irritated or angry during the day? 
M – body Mass index above 85%? 
S – Does your child usually Snore? 
L – Does your child sometimes have Laboured breathing at night? 
E – Ever noticed a stop in your child’s breathing at night? 
E – Does your child have Enlarged tonsils or adenoids?  
P – Does your child have Problems with concentration? 
Y – Does your child often Yawn or is often tired/sleepy during the day? 
Child version 
I  – Are you angry a lot? 
M – Filled in by doctor: body Mass index above 85%? 
S – Do you snore at night? 
L – Did your parents or a friend tell you that your breathing is “difficult” at night? 
E – Did your parents or a friend tell you that you stop breathing at night? 
E – Do you have problems with your tonsils or adenoids (glands inside your mouth)?  
P – Is it difficult for you to focus (at school or at home)? 
Y – Do you feel tired or sleep a lot? 
Note. Adapted from Kadmon et al., 2014. 
 Chervin, Hedger, Dillon, and Pituch (2000) developed and validated a pediatric sleep 
questionnaire for childhood SDB referred to in the literature as the Sleep-Related Breathing 
Disorders (SRBD) questionnaire. This screening tool was initially created for use in research 
studies investigating children for the presence of OSA. While this study was conducted in 2000, 
it was hand selected for this integrative review as a study of importance, as it continues to be 
widely utilized and cited by researchers studying childhood SDB and OSA. The SRBD 
questionnaire focused on three domains for childhood SDB: snoring, excessive daytime 
sleepiness, and inattentive/hyperactive behaviour (Chervin et al., 2000).  
 The study took place between April 1996 and September 1998, and included two cohorts 
of children between the ages of 2-18 years. The first cohort had previously undergone PSG and 
was confirmed to have OSA with AHI ≥5 events/hour (n=54, mean age 9.3 ±4.1), and the second 
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cohort was recruited from a general pediatric clinic as the control group (n=108, mean age 7.0 
±3.8; Chervin et al., 2000). Parents completed a 50-item “yes/no/don’t know” response format 
questionnaire regarding their child’s sleep and behaviour. The questionnaire took approximately 
20-30 minutes to complete. To assess the test-retest reliability, a small group of parents (n=21) 
were asked to repeat the questionnaire 2-4 weeks after the initial response (Chervin et al., 2000). 
The sample was randomly divided into category A and category B. Results from category A 
were used to develop a scale using logistic regression models, category B was used to verify 
validity of the scale. The researchers analyzed the questionnaire and PSG results to determine 
which questions were most useful to detect OSA, with the goal of producing a concise 
questionnaire of approximately 20 questions, which could be completed in five minutes (Chervin 
et al., 2000). 
 This study identified 22 questions that correlated to a diagnosis of OSA. Calculations 
determined using a receiver operator curve (ROC) found that the cut-off to indicate the presence 
of OSA was 0.33 (33% of the 22-questions). Thus when 8 of the 22 questions of the SRBD 
questionnaire were positive, the questionnaire had a sensitivity of 83%, a specificity of 87%, and 
a positive predictive value of 85.7% (Chervin et al., 2000).  
 The main strength of this study is the generalizability to a wider population. This was 
achieved by recruiting children from a general pediatric population, and identifying inclusion 
and exclusion criteria that focused on children without additional comorbidities. Furthermore, 
there were careful steps taken to ensure valid results including, asking parents to repeat the 
questionnaire, and recruiting children from a community setting to serve as the control group. As 
the sample was children between the ages 2-18 this limits application to the current research 
question (2-8 year old children) thereby raising uncertainty of the sensitivity and specificity of 
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the questionnaire within a younger age group since the results were not stratified by age groups. 
Furthermore, the researchers used an OSA criteria of AHI  ≥5 events/hour, which aligns with the 
American Academy of Sleep Medicine definition of moderate to severe OSA. Thus, this would 
impact the external validity, as this questionnaire likely would not be as sensitive at detecting 
mild cases of OSA, defined as an AHI <5 events/hour. 
 In summary, the 22-item SRDB questionnaire is an easy to administer screening tool that 
focuses on three key indicators of childhood OSA: snoring, daytime sleepiness, and 
inattention/hyperactivity behaviours. This screening tool has excellent sensitivity and specificity 
when using an AHI ≥5 events/hour, however, the reliability for detecting mild OSA (AHI <5 
events/hour) and in younger age groups (2-8 years of age) is undetermined. Overall, this 
screening tool would be useful to identify children who have moderate to severe OSA and 
require prompt referral and treatment.  
 The final study by Biggs et al. (2014a) introduced the childhood OSA screening tool, the 
Pediatric Sleep Survey Instrument (PSSI). The PSSI is a 45-item 4-point Likert scale 
questionnaire based on six sleep related domains: sleep routine, bedtime anxiety, morning 
tiredness, night arousals, sleep disordered breathing, and restless sleep (Biggs et al., 2014a). The 
PSSI has been previously been validated by a longitudinal study of 1,845 community-based 
children aged 5-10 years old (Biggs, Kennedy, Martin, van den Heuvel, & Lushington, 2012). To 
build on the 2012 study, Biggs et al. (2014a) conducted a cross-sectional study based out of 
Melbourne, Australia, to compare the PSSI with PSG to assess the validity and clinical 
application of the PSSI for screening children for OSA. Two groups of children (clinical cohort 
n=87, 62M/25F) and a nonsnoring community sample (n=55, 28M/27F) aged 5-10 years 
completed the study between 2007-2008. Researchers compared the results of the PSSI against 
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PSG, and two additional sleep-related questionnaires assessing quality of life (OSA-18), and 
daytime sleepiness (Pediatric Daytime Sleepiness Tool). Using >5 events/hour as the accepted 
cut-off value for OSA, a PSSI score of five was found to have an accuracy of 70%, with a 
sensitivity of 94% and specificity of 76% (Biggs et al., 2014a). The PSSI also had high 
sensitivity for measuring additional sleep-related domains that indicate daytime sleepiness, as 
validated by analysis with the additional questionnaires (Biggs et al., 2014a).  
 A significant strength of this study was the comparison between children referred for 
PSG and healthy children from the community, as studies largely use only children whom are 
referred to sleep clinics in their cohort. This enhanced the external validity and relevance to the 
research question. With similarities between ethnicity, population health, and health care 
structure in Canada and Australia, this Australian study is applicable in the Canadian setting. A 
limitation to methodology of this study is that parents must sequentially complete three long 
questionnaires; this could result in an inadvertent response bias due to lengthy paper work, as 
well as inaccuracy due to the subjective nature of evaluating sleep via a 4-point Likert scale. 
However, the results of this study provided evidence that the PSSI can accurately and reliably 
enhance primary care providers decision-making towards which children with suspected OSA 
require referral. Overall, while the PSSI contains more items than other OSA screening 
questionnaires, the PSSI is a screening tool that could easily be implemented into practice in the 
primary care setting. 
 This section reviewed four validated screening tools for childhood OSA that can be used 
in the primary care setting, as well as one systematic review that provides valuable diagnostic 
data regarding common indicators of childhood OSA. Overall, each of the studies can help with 
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early recognition of childhood OSA, and help primary care providers with clinical decision 
making in regards to which children to refer.  
Use of Subjective and Objective Variable Screening Tools  
 The second theme identified in the literature review analysis evaluated screening tools 
that utilized subjective and objective variables to create risk stratification scores associated with 
OSA. As a goal to improve the sensitivity and specificity of the questionnaire based screening 
tools, research has been conducted on the addition of variables obtained through physical 
examination to better identify children with OSA. The following three studies examine screening 
tools that take into account both subjective and objective variables contributing to childhood 
OSA. 
 The first subjective and objective variable screening tool analyzed is a quantitative cross-
sectional study by Kang et al. (2015). This study aimed to compare the diagnostic abilities of 
history and anatomical findings in diagnosing pediatric OSA. The anatomical findings included: 
tonsil size, using grade III-IV to define tonsillar hypertrophy; adenoid hypertrophy, determined 
using lateral cephalometric radiographs and using adenoidal depth/nasopharyngeal diameter ratio 
≥0.67 to define adenoid hypertrophy; and obesity, defined as a BMI >95th percentile for a child’s 
age and gender (Kang et al., 2015). The history was obtained through a questionnaire that 
included questions regarding daytime and night-time symptoms of OSA in children. The daytime 
symptoms included daytime sleepiness, hyperactivity, attention problems, depression, low self-
esteem, shyness, and low academic performance (Kang et al., 2015). The night-time symptoms 
of OSA included snoring patterns, breathing pauses, awakening at night, bedwetting, nightmares, 
and diaphoresis (Kang et al., 2015). Each child in the study underwent full-night PSG in a sleep 
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laboratory, and statistical analysis was conducted to determine the sensitivity and specificity of 
each childhood OSA indicator.  
 The study recruited 222 children (mean age of 7.3 years ± 3.7, male n=149) with 
symptoms suggestive of OSA (Kang et al., 2015). Participants were recruited from respiratory, 
pediatric, and otolaryngology clinics between June 2012 and January 2014. Exclusion criteria 
included: 1) prior tonsil, adenoid, or pharyngeal surgery, 2) craniofacial abnormalities, 3) genetic 
disorders, neuromuscular diseases, cognitive deficits, or mental retardation, and 4) children 
younger than 12 months of age (Kang et al., 2015). Thus, the demographics of the children in 
this study closely matched the population of interest. Of the children in the study, 52.3% were 
found to have OSA diagnosed by PSG with an AHI >1 event/hour (Kang et al., 2015).  
 Results of this study found that of the anatomical indicators with the greatest clinical 
significance (p <0.05) included: tonsillar hypertrophy, with a sensitivity of 76.7% and specificity 
of 65.1%; adenoid hypertrophy, with a sensitivity of 75.0% and a specificity of 55.7%; and 
obesity, with a sensitivity of 28.4% and a specificity of 85.8% (Kang et al., 2015). Historical 
measures with the greatest clinical significance (p <0.05) for identifying childhood OSA 
included: snoring >5 nights/week; snoring for >3month; breathing pauses; and awakening (Kang 
et al., 2015). Snoring >5nights/week had a sensitivity of 76.7% and a specificity of 48.1%; 
snoring for >3 months had a sensitivity of 83.6% and a specificity of 34.9%; breathing pauses 
had a sensitivity of 42.2% and a specificity of 87.7%; and finally, awakening during sleep had a 
sensitivity of 35.7% and a specificity of 75.0% (Kang et al., 2015). Using a likelihood ratio chi-
square model, the researchers determined the likelihood ratio of diagnosing OSA with the 
anatomical model 56.7%, historical model 37.8%, and combined model 87.1% (Kang et al., 
2015). Therefore, a combination of anatomical and historical measures improved the diagnostic 
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probability. Furthermore, this study divided the clinical measures by age group <6 years and >6 
years. Tonsillar and adenoid hypertrophy were statistically significant (p <0.001) findings in 
children with OSA who were <6 years of age, whereas obesity was more significant (p <0.001) 
in children >6 years of age (Kang et al., 2015). Furthermore, mouth breathing had statistical 
significance (p 0.01) for children <6 years of age, but not for children >6 years of age. Snoring 
and breathing pauses were significantly associated with both age groups.  
 Strengths of this study were the division of demographic age groups with OSA which 
facilitated further differentiate between risk factors associated with age; this has strong 
applicability to the research question, as the focus is on children between 2-8 years of age 
specifically to identify children as risk for adenotonsillar hypertrophy. Limitations of this study 
included the recruitment of children from clinics specializing in childhood SDB, including OSA, 
and limiting the generalizability to use in the primary care setting. Another significant limitation 
was the mean BMI percentile (62.2 ± 30.7) of the children in the study, thus obesity was not 
prevalent among the population in the study. This could limit the external validity associated 
with obesity as an anatomic indicator of childhood OSA, as in North America, childhood obesity 
is more prevalent than the population in this study.  
 To follow-up with research findings from their 2015 study, Kang et al. (2016) conducted 
a quantitative cross-sectional study with the aim of identifying children with OSA through the 
development of a Clinical Risk Assessment Model. The Clinical Risk Assessment Model applies 
the variables of tonsil size, adenoid size, body mass index, clinical symptoms of OSA, and the 
OSA-18 survey to determine correlating OSA risk (Kang et al., 2016). A sample of 310 children 
with suspected SDB was recruited from respiratory, pediatric, and otolaryngology clinics in 
Taiwan (Kang et al., 2016). Data was collected through physical assessment to measure tonsil 
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size, adenoid size, and body weight; OSA-18 survey; and parents’ report of clinical symptoms, 
and each participant underwent PSG (Kang et al., 2016). Using multivariable logistic regression 
analysis, results of the study were compiled to create the Clinical Risk Assessment Model 
scoring system. The Clinical Risk Assessment Model found predicting mild OSA (AHI >1 
events per hour) had a sensitivity of 72.9% and a specificity of 65%, and moderate to severe 
(AHI >5 events/hour) OSA had a sensitivity of 77.5% and specificity of 56.9% (Kang et al., 
2016). Additional data extrapolated from this study identified witnessed breathing pauses as 
having the highest diagnostic accuracy for predicting childhood OSA (Kang et al., 2016). 
Snoring >5 nights/week, snoring occurring for >3 months, tonsillar hypertrophy, and obesity 
were additional indicators that had high diagnostic value. 
 The primary strength of this study was the detail demonstrating internal and external 
validity; the researchers comprehensively disclose the participant recruitment strategy, 
demographics, inclusion and exclusion criteria, and methodology. This study has strong 
generalizability due to the sample size, and the mean age of 7.6 years of age for the participants, 
making this study relevant to the research question. Additionally, the statistics for each variable 
were clearly displayed showing the probability (p <0.05), and the odds ratio with a confidence 
interval of 95%, this enhances the reliability and rigour of the study. One limitation of this study 
was the location, being in Taiwan. There was no mention to the ethnicity of the children in the 
study, however, BMI averages among children in North America and Taiwan may differ based 
on genetics and lifestyle. Furthermore, differences in the countries health care system, medical 
models, and cultural norms regarding preventative health screening could impact the 
transferability of the findings to children in Canada.  
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 This follow-up study by Kang et al (2016) provides useful information regarding 
indicators of childhood OSA.  Furthermore, evaluating multiple AHI (both >1 and > 5 
events/hour) cut-offs provides data regarding both mild and moderate to severe OSA. Overall, 
this study demonstrated that the variables of adenoid size, tonsil size, and body weight are 
significant indicators associated with the development of OSA. However, the sensitivity and 
specificity of the Clinical Risk Assessment Model did not appear to perform better than the more 
convenient and simpler questionnaires introduced in the previous section. Yet, the cut-off of AHI 
≥1 event/hour provided improved recognition of mild OSA than the questionnaire based 
screening tools.  
 In the study by Villa et al. (2013) a screening tool for childhood OSA, the Sleep Clinical 
Record was introduced and validated in a study of 279 children (mean age 6.1 ± 3.1 years). The 
Sleep Clinical Record is a risk stratification screening tool that combines data from three 
domains: physical examination, subjective symptoms, and clinical history, and provides a SDB 
clinical score (Villa et al., 2013). The physical exam assessed for the presence of tonsillar 
hypertrophy, adenoidal hypertrophy, obesity, oral breathing, nasal obstruction, nasal septal 
deviation, dental malocclusion, narrow palate, or pathological position of the mandible (Villa et 
al., 2013). Subjective symptoms were determined from a parental questionnaire asking yes/no 
questions about mouth breathing, habitual snoring, witnessed apneic episodes, frequent 
awakenings, agitated sleep, daytime somnolence, and headaches (Villa et al., 2013). Clinical 
history aimed to investigate the presence of symptoms of inattention and hyperactivity through 
the completion of a validated 18-question ADHD rating scale.  All the children in this study 
received a PSG sleep study, and data were compiled to determine a scoring system for the Sleep 
Clinical Record. This study determined that a score of ≥6.25 was a positive result, as it had a 
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positive correlation of AHI >1 event/hour, resulting in a PSG diagnosis of OSA (Villa et al., 
2013). A positive sleep clinical score had a sensitivity of 96.05%, a specificity of 67%, positive 
likelihood ratio of 2.91, negative likelihood ratio of 0.06, and accuracy of 88.2% (Villa et al., 
2013). 
 The main strength of Sleep Clinical Record risk stratification tool was the inclusion of a 
combination multiple indicators of childhood OSA: physical examination, patient history, and 
clinical symptoms.  The methodology of this study was clearly explained, and the researchers 
used blinding between the clinical person who administered the Sleep Clinical Record and the 
PSG assessment to eliminate bias. This study is also generalizable to the research question, as the 
mean age group was 6.1 ± 3.1 years of age, and it identified the same exclusion criteria as the 
research question. The high sensitivity of this screening tool minimized false negatives, therefore 
it can be used to confirm suspicions of childhood OSA, and determine children who need referral 
for diagnosis and treatment, rather than for PSG. However, the researchers did find that false 
negatives were more common in younger children, with a mean age of 4.6 ± 1.8 years. The lower 
specificity of the Sleep Clinical Record is due to a high number of false positives, which was 
found to be associated with neurological symptoms that can mimic OSA, such as periodic limb 
movement, EEG paroxysmal activity, and nocturnal chocking. Children with these symptoms 
should also be referred for abnormal sleep behaviours; therefore sending children with false 
positives for PSG would be an appropriate action regardless of the OSA risk.  
 Additional information gained from this study includes the correlation of ADHD 
behaviours and tonsillar hypertrophy with SDB. This study found that ADHD behaviours are 
consistent with SDB, such as primary snoring, but not specific to OSA. This is a common 
finding throughout the research, which places emphasis on the need for more information about 
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the negative consequences of primary snoring in childhood. Tonsillar hypertrophy, defined as 
tonsils at grade 3 and 4, had a higher sleep clinical score. Furthermore, children with tonsillar 
hypertrophy demonstrated lower oxygen saturations, and a higher AHI on PSG, indicating more 
severe OSA. Interestingly, in this study, tonsillar hypertrophy was more common in children 
with a lower BMI, however, this data was likely identified because children with obesity with or 
without tonsillar hypertrophy would be more likely to be referred to a pediatric sleep clinic. This 
introduces the main limitation of this study, as only children referred for diagnostic evaluation at 
a pediatric sleep centre were included in this study. This minimizes the external validity, as is 
does not take into account children from a community based primary care setting. The 
researchers recognized this limitation and suggested that the tool only be used in children who 
have been referred for snoring, apneas, or oral breathing during sleep, as a tool to determine 
which children are candidates for PSG, and not as a screening tool in a general pediatric 
population.  
 The three studies discussed provide relevant information regarding objective clinical 
indicators of childhood OSA that are discovered during the physical exam. Remarkably, the 
results of the screening tools with both subjective and objective variables are not significantly 
more sensitive or specific than the simpler questionnaire based screening tools. Nonetheless, 
valuable information is retrieved from the analysis of these studies, primarily further validation 
that enlarged tonsils, adenoids and increased BMI are strongly correlated with childhood OSA.  
The Feasibility of Home Based Nocturnal Oximetry in Children with Suspected OSA 
 Home based nocturnal oximetry sleep studies are widely used among adults with 
suspected OSA for the screening and diagnosis of uncomplicated OSA. However, currently in 
BC, options for in-home sleep studies for children do not exist. Increased recognition of the 
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adverse effects of delayed diagnosis and untreated childhood OSA combined with the predicted 
increased prevalence due to the childhood obesity epidemic, in addition to poor province-wide 
access to pediatric PSG services demands improved screening guidelines for childhood OSA. 
The following three studies examine the feasibility of home based nocturnal oximetry for 
pediatric OSA screening, and represent the third theme identified during the literature analysis 
for this integrative review. 
 The first article to discuss in-home screening tools for childhood OSA is a quantitative 
cross-sectional study by Alvarez et al. (2015). In this study, the researchers aimed to develop a 
screening tool for childhood OSA by recording and analyzing multiple variables obtained 
through nocturnal oxygen saturations (SpO2). The sample consisted of 176 children (mean age 
6.95 ± 3.55; 55.11% male) that were referred to the Pediatric Sleep Unit at a Chicago Hospital 
for suspected OSA (Alvarez et al., 2015). The children underwent PSG, and the SpO2 recordings 
generated by the PSG provided the corresponding data. The researchers tested three 
algorithms—linear discriminant analysis, quadratic discriminant analysis, and logistic 
regression—against several clinical apnea-hypopnea index (AHI) cut-offs (1, 3, and 5 
events/hour) to analyze the screening ability at a range of OSA severity thresholds. This study 
found that the preferred algorithm of automated analysis of SpO2 recordings provides valuable 
screening information for children with mild and moderate OSA (AHI ≥1 and ≥3 events/hour), 
and can additionally provide diagnostic data for a child who tests positive with an AHI ≥5 
events/hour (Alvarez et al., 2015). Table 8 demonstrates the performance of automated analysis 
with each AHI cut-offs. Children who test positive with AHI ≥5 events/hour using this screening 
instrument diagnostically have OSA, as there is 100% specificity and 100% positive predictive 
value, ensuring there are no false negatives (Alvarez et al., 2015).  
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Table 8 
Diagnostic Performance of Automated Analysis  
AHI cut-off Sensitivity Specificity PPV NPV Accuracy 
5 events/hour 71.4 100.0 100.0 84.0 88.6 
3 events/hour 71.8 83.9 84.9 70.3 77.1 
1 event/hour 64.7 83.3 95.7 29.4 77.1 
Note. Adapted from Alvarez et al., 2015. 
 The design and methodology used in this study supported strong internal validity for the 
accuracy of the results through establishing statistical power for each variable. For analysis of 
each AHI cut-off threshold, the sample population was randomized into independent training and 
test sets, to eliminate bias (Alvarez et al., 2015). A weakness of this study design was its failure 
to explain any inclusion or exclusion criteria for the sample population, diminishing the external 
validity. Additionally, there was selection bias, as the children in the study were all referred to a 
sleep clinic, making it difficult to determine if the results are generalizable to the primary care 
setting. Subsequent research will need to determine if this screening tool is accurate in the home 
setting, as it has only been performed on a small and specific sample in a highly controlled 
setting of the sleep laboratory. Overall, with strong statistical and clinical significance, this study 
proves that in-home nocturnal oximetry can provide OSA screening for mild to moderate OSA, 
and has comparable positive predictive value to the gold standard of PSG for children with 
moderate to severe OSA. Thus, this study is relevant to the research question, providing evidence 
that nocturnal oximetry automated analysis possesses potential for use as a screening tool for 
pediatric OSA for NPs in the primary care setting, and is highly accurate for children with 
moderate to severe OSA. 
 The next study by Garde et al. (2014) similarly assessed the ability of in-home nocturnal 
oximetry as a screening tool for childhood OSA. This quantitative cross-sectional study 
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performed at BC Children’s Hospital investigates the Phone Oximeter, a screening tool 
integrated into a smartphone, which combines both SpO2 and pulse rate variability (PRV) to 
identify a detailed sleep analysis. The authors hypothesized that PRV improves the sensitivity of 
SpO2 to identify OSA events, thus, a tool that combines SpO2 and PVR may improve accuracy. 
Children recruited for this study underwent an in-laboratory polysomnography sleep study, with 
the Phone Oximeter applied in tandem. The polysomnography and the Phone Oximeter do not 
influence the results of either test, allowing data from both tests to be collected simultaneously, 
allowing for impartial comparison to assess accuracy (Garde et al., 2014). In this study, the 
researchers used an AHI ≥5 events/hour as indicative of OSA.  
 The researchers recruited 146 children (OSA: n=56, mean age 8.8 ±4.6; Non OSA: n=90, 
mean age 9.3 ±4) who were referred to BCCH for PSG (Garde et al., 2014). The Phone Oximeter 
found that children with OSA had higher AHI during REM sleep with increased number of 
desaturations below baseline (Garde et al., 2014). Furthermore, children with OSA showed 
higher heart rates and higher overnight dispersion of PRV. During PRV analysis, children with 
OSA had a higher low frequency/high frequency ratio, which reflects higher sympathetic activity 
due to episodes of OSA (Garde et al., 2014). Overall, the Phone Oximeter had an accuracy of 
84.9%, with a sensitivity of 88.4%, specificity of 83.6%, positive predictive value of 76.9%, and 
negative predictive value of 92.6% (Garde et al., 2014).  
 The methodology and results in this study were clearly defined, enhancing the reliability 
and rigour. This study was conducted at BCCH, which reflects the same population and location 
that prompted the research question. Additionally, both the research question and this study aim 
to address the same issue, thus, this study has clear relevance to the research question. However, 
the researchers failed to disclose the demographics of the participants and any exclusion criteria, 
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therefore, it is difficult to assess the external validity and generalizability to the population 
included in the research question. Furthermore, the mean age of the children recruited for this 
study is at the higher end of the age range targeting in the research question. As the study has 
only been performed in the sleep laboratory setting, it is not yet an applicable tool for primary 
care practice as it has not been determined how accurate the Phone Oximeter will be in the home 
setting. Furthermore, the researchers do not include additional AHI cut-offs; therefore, the utility 
of this tool in identifying children with mild OSA is unknown. Overall, this is a valid study 
providing background evidence of an innovative screening tool that shows promise for the future 
of screening for pediatric OSA. The Phone Oximeter could easily be prescribed by a NP working 
in primary care settings, and has great potential to help determine which children require referral 
for OSA, and to help triage children with more severe OSA who require prompt PSG and 
treatment.  
 The final study reviewed for this integrative review is a retrospective cross-sectional 
study by Pavone at al. (2017) exploring the utility of in-home nocturnal oximetry in children 
with adenotonsillar hypertrophy and suspected OSA. As adenotonsillectomy is widely 
recognized as first-line treatment of OSA, this study aims to explore whether nocturnal oximetry 
analysis could predict which children with suspected OSA would receive adenotonsillectomy. 
The researchers recruited 380 children between the ages of 1-18 years (median age 4.1 years) 
from a Children’s Hospital in Rome, Italy (Pavone at al., 2017). Children consecutively 
underwent in-home nocturnal pulse oximetry analyzed with the McGill Oximetry Score (MOS), 
followed by an evaluation with an otorhinolaryngologist (Pavone at al., 2017). The MOS is a 
well-recognized validated tool that was developed in Montreal, Canada; MOS correlates with 
PSG to detect and grade the severity of pediatric OSA (Pavone at al., 2017). The children in this 
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study had a minimum of three years of follow-up to determine relationship of nocturnal oximetry 
results and future adenotonsillectomy. Researchers hypothesized that analysis of MOS with pulse 
oximetry can expedite diagnosis and treatment of children with adenotonsillar hypertrophy 
requiring adenotonsillectomy for OSA. 
 Saturation and pulse rate data were extracted and evaluated. MOS of 2, 3, and 4 were 
considered abnormal and diagnostic for increasing severity of OSA, while a MOS of 1 was 
considered inconclusive and unable to rule out OSA (Pavone et al., 2017). Among the study 
population, 45 children (12%) had abnormal MOS, and 83 children (21.8%) underwent 
adenotonsillectomy (median age 3.4 years; 74.7% male; Pavone at al., 2017). Using chi-squared 
and logistic regression models, abnormal MOS was determined to be a strong predictor of 
adenotonsillectomy (Pavone at al., 2017). Among the children who underwent 
adenotonsillectomy, mean and minimum SpO2 recordings were lower, and pulse rate variability 
(PRV) was significantly higher. Overall, children with abnormal MOS were nearly 20 times 
more likely to undergo adenotonsillectomy (Pavone at al., 2017). 
 The principle strength of this study is the retrospective methodology, ensuring the 
otorhinolaryngologist evaluations were blinded from the MOS results as well as the aim of the 
study. The exclusion criteria and median age range were clearly displayed and match the 
eligibility criteria of the current research question, increasing the generalizability. The main 
indications for adenotonsillectomy included recurrent disabling upper airway infections over a 
certain time period, or OSA diagnosed by a sleep study. However, the researchers do not disclose 
how many otorhinolaryngologists were included in deciding which children would undergo 
adenotonsillectomy during the course of this study. This could contribute to a bias as 
determining eligibility for adenotonsillectomy may differ among surgeons. Overall, this study 
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confirms that in-home pulse oximetry using both MOS and PRV is useful to predict the need for 
adenotonsillectomy. Thus, conducting in-home nocturnal oximetry would be beneficial to 
determine need for referral, or to expedite children who require prompt referral for management 
of OSA.   
 Home based nocturnal oximetry sleep studies capturing both oxygen desaturations and 
pulse rate variability have the ability to capture important sleep related data. Therefore, based on 
the analysis of these studies home based nocturnal oximetry could be a feasible screening tool 
for childhood OSA, or used within a step-wise approach towards addressing suspected OSA.  
 In summary, an comprehensive search identified 11 articles of significance to answer the 
research question: what strategies can NPs, as primary care providers, implement to improve 
screening for OSA in children between the ages of 2-8 years to determine need for referral? 
Critical appraisal of these identified articles revealed three themes: 1) use of validated pediatric 
OSA screening questionnaires; 2) use of subjective and objective variable screening tools; and 3) 
the feasibility of home-based nocturnal oximetry in children with suspected OSA. The following 
chapter will include a discussion and recommendations of how the findings from this integrative 




 In this chapter, synthesis of the 11 articles analyzed in the findings chapter and their 
implications for primary care providers is discussed. Childhood obstructive sleep apnea (OSA) is 
a health challenge that can result in long-term medical and neurodevelopmental health challenges 
(Blechner & Williamson, 2016; Marcus et al., 2012; Tan et al., 2016). Screening for OSA occurs 
in the primary care setting, and is the responsibility of primary care providers. Multiple clinical 
practice guidelines and clinical practice tools recommend screening for childhood OSA by 
asking about the presence of snoring (Kaditis et al., 2015; Kothare et al., 2015; Marcus et al., 
2012). According to the AAP clinical practice guidelines, all children who snore should be 
referred for polysomnography (PSG) or to an otolaryngologist (Marcus et al., 2012). However, 
based on the evidence, up to 75% children are not being screened for OSA in the primary care 
setting, as recommended by the AAP 2012 clinical practice guidelines (Erichson et al., 2012; 
Faruqui et al., 2011). This reflects a significant gap in both primary care provider’s and the 
general public’s awareness and education regarding childhood OSA (Mukherjee et al., 2015). 
Inadequate screening results in delayed recognition and investigation, which leads to increased 
time to treatment. Delayed investigation and treatment is further compromised, since British 
Columbia does not have adequate capability to complete diagnostic PSG sleep studies for every 
child who snores (Garde et al., 2014). Thus, primary care providers require additional tools to 
enable them to screen children for OSA in order to determine which children require referral to 
specialists. Reviewing and analysing the 11 key research papers provided insight towards the 
question: what strategies can NPs, as primary care providers, implement to improve screening 
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for OSA in children between the ages of 2-8 years to determine need for referral? These findings 
will be discussed.  
Screening Tools Used in the Primary Care Setting  
 While screening for childhood OSA is indicated in the primary care setting, aside from 
asking about snoring, guidelines do not recommend a specific tool to assist with screening. In 
completing this integrative review, four questionnaire based screening tools, and two screening 
tools involving subjective and objective variables for childhood OSA were identified that may 
support screening approaches for the NP working in primary care.   
 Questionnaire based screening tools. Questionnaire based screening tools are widely 
used in the primary care setting. The primary advantage to a questionnaire based screening tool 
is the way in which relevant questions can help collect historical and current patient data 
focusing on parameters that may indicate OSA. Certain screening tools, such as the PHQ-9 and 
GAD-9, are universally recognized and allow a common language among health care providers. 
Benefits of questionnaire based screening tools include low cost and ease of use by both the 
primary care provider, and the parent completing the questionnaire. An additional advantage of 
questionnaire based screening tools is it they can be embedded directly into an electronic medical 
record. This allows easy retrieval of the questionnaire, and the ability to track data trends. 
Questionnaire based screening tools have versatility in the primary care setting; they can be 
completed by literate patients in the waiting room, or they can be completed during the 
appointment and integrated into the documentation of patient history. In addition, repeated use of 
the same questionnaire over time can monitor a child’s trend of increasing or decreasing severity. 
Table 9 identifies and compares each of the questionnaire based screening tools identified in this 
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integrative review. This table also delivers validity of each of the questionnaire based screening 
tools and the apnea-hypopnea index (AHI) used to define OSA in each individual study.  
Table 9 
Comparison of Questionnaire Based Screening Tools   
Screening Tool Details AHI cut-off Sensitivity Specificity 
I’M SLEEPY 
(Kadmon et al., 
2014) 
8-item questionnaire. 




SRBD (Chervin et 
al., 2000) 
22-item questionnaire 




PSSI (Biggs et al., 
2014a) 
45-item questionnaire 





Spruyt and Gozal 
(2012) six 
hierarchically 
arranged questions  
6-item questionnaire 







 Both the six hierarchically arranged questions to aid the screening of children with 
suspected OSA by Spruyt and Gozal (2012), and the I’M SLEEPY screening tool by Kadmon et 
al. (2014) are short screening tools that can be used while taking a history of a child with 
suspected OSA. The six hierarchically arranged questions have value to determine red flag 
features that would require prompt referral and investigation. The I’M SLEEPY screening tool 
encompasses many of the common features and risk factors of childhood OSA; the easy to 
remember mnemonic can help primary care providers to recall important features of childhood 
OSA when taking a history. Brief questioning is effective for early recognition, however a 
limitation to this form of screening tool is that it does not provide a comprehensive assessment of 
the child’s sleep. Two more comprehensive screening tools analyzed are the PSSI screening tool 
by Biggs et al. (2014a), and SRDB questionnaire by Chervin et al. (2000). These screening tools 
use longer questionnaires that can be printed out and provided to parents to complete when 
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childhood OSA is suspected. The PSSI includes six domains of childhood sleep: sleep routine, 
bedtime anxiety, morning tiredness, night arousals, sleep disordered breathing, restless sleep, and 
four additional questions pertaining to enuresis, sleep walking, hyperhidrosis, and bruxism 
(Biggs et al., 2014a). Thus, the PSSI is useful to evaluate children’s sleep, when concerns are 
identified and a full history of the child’s sleep is warranted. For example, a child presenting 
with behavioural or emotional concerns, attention-deficit hyperactive disorder, or identified 
learning disabilities would benefit from a full evaluation of sleep. Additionally, the use of a 
Likert scale shows increasing degrees of severity, therefore, it is useful as a tool to track 
symptoms over time, if used by the same caregiver to minimize continuity error (Biggs et al., 
2014a). The SRDB questionnaire differs from the PSSI, as it asks questions very specific to 
OSA, thus, has utility when a child is known to snore, and more information is needed to 
determine other signs, symptoms, and risk factors (Chervin et al., 2000).  
 All four of the above mentioned screening tools are freely accessed online via the original 
research papers, or a simple Google search. Overall, each of the questionnaire based screening 
tools are useful for primary care providers to obtain a history for children with suspected OSA, 
and their use can contribute to early recognition of childhood OSA. However, the data on 
screening tools must be interpreted with caution, as they do not provide new evidence to support 
decision making for referrals. Snoring continues to be the most sensitive indicator for childhood 
OSA, and the main indication for referral. Thus, any child who snores on a regular basis requires 
referral, regardless of their score using one of the above screening tools.  
 Subjective and objective variable screening tools. In addition to screening tools that 
focus on the subjective features of childhood OSA, two screening tools examined the key 
components of an objective physical exam: the Sleep Clinical Record by Villa et al., (2013), and 
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the Clinical Risk Assessment Model by Kang et al., (2016). Table 10 identifies and compares 
these two screening tools and their validity. Since a physical exam is warranted for any child 
with suspected OSA, the inclusion of anatomic findings into a screening tool would not involve 
increased burden or time for the primary care provider. Risk stratification tools that provide a 
concrete numerical value to quantify the risk of childhood OSA can be used to track symptoms 
over time and identify increasing severity that can help primary care providers decision-making 
regarding referrals. A numerical value also links to risk, and has the advantage of being easy to 
explain, thus, it can be used as an educational tool for family members.  
Table 10 
Comparison of Subjective and Objective Variable Screening Tools   
Screening 
Tool 




et al., 2016) 
Score >10 is mild OSA 
Score ≥12 is moderate-severe 
OSA 






et al., 2013) 




 The Clinical Risk Assessment Model found five risk factors that were best able to predict 
childhood OSA; adenoid percentage (adenoidal depth/nasopharyngeal diameter) for age, obesity 
for age, tonsil hypertrophy, and breathing pauses (Kang et al., 2016). The disadvantage to using 
this screening tool is that to determine adenoid percentage, a lateral cephalic radiograph is 
performed (Kang et al., 2016), which is associated with additional inconvenience, cost, and risks 
associated with radiation. An advantage to using the Clinical Sleep Record by Villa et al. (2013) 
is that it can be completed in one primary care visit. The tool prompts the primary care provider 
to complete a comprehensive physical including: investigating oral breathing, nasal obstruction, 
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septum nose deviation, tonsillar hypertrophy, dental and skeletal malocclusions (open bite/deep 
bite/cross bite/over bite), palate position, and adenoid phenotype (Villa et al., 2013). The benefit 
of this screening tool is that it describes the relevant components of the focused head, nose, 
mouth, and throat physical exam when childhood OSA is suspected. The Clinical Sleep Record 
includes photos as reference to assist providers to accurately assess the above objective features. 
A limitation is that many of the aspects of the physical exam could have slight variations; for 
example a mildly narrow palate may not be evident to all providers. The Clinical Sleep Record 
follows a yes/no format and does not account for severity; thus, the final result could differ 
significantly for different providers. Overall, the sensitivity and specificity of the subjective and 
objective variable screening tools are not sufficient to exclude PSG towards a diagnosis of OSA. 
Furthermore, the sensitivity and specificity is not significantly improved from the questionnaire 
based screening tools. However, the addition of specific objective variables does provide more 
information that could be useful to guide treatment options, which is out of the realm of primary 
care. For this reason, screening tools that include the measurement of objective variables may be 
better suited to specialists, not for screening in the primary care setting. 
 Overall, the questionnaire based screening tools, and the subjective and objective variable 
screening tools provide important aspects of inquiry when completing a patient history. 
Furthermore, two of these tools draw primary care provider attention to the need for a focused 
head, nose, mouth, and throat physical exam, as well as assessing BMI when completing an 
assessment on a child with suspected OSA. Appendix D provides synthesis of the analyzed 
screening tools. The first column is a compilation of the subjective and objective features of 
childhood OSA that primary care providers should include in the history and physical assessment 
for a child with suspected OSA. The middle column provides the validity of each of the clinical 
 62 
feature as reported through the systematic review by Certal et al. (2012) and the quantitative 
study by Kang et al. (2015). The third column includes the screening tools that recognize each of 
the clinical indicators. It is significant to note that snoring and apnea/witnessed pauses have the 
strongest validity to predicting OSA, thus, are clinical features recognized by the majority of 
screening tools. As noted in Table 9 and Table 10, the sensitivity and specificity of each of the 
screening tools are not significantly different, thus, choosing one screening tool over another for 
primary care use cannot be recommended. It is recommended that primary care providers 
become comfortable with using one tool in practice. Provider familiarity with a tool can build 
confidence in pattern recognition and support regular use ensuring that the questions about risk 
of OSA, outside of snoring, are clearly defined in line with the recommendations from the 2012 
AAP clinical practice guidelines. Appendix E provides a summative table to help primary care 
providers make an informed decision regarding which screening tool to use in practice. A word 
of caution is necessary for primary care providers that screening tools are not able to achieve 
sensitivity and specificity with sufficient diagnostic accuracy to rule in or rule out OSA. 
 In summary, the aim of this integrative review was to determine strategies primary care 
providers could implement to improve screening for OSA in children between the ages of 2-8 
years to determine need for referral. In reviewing the literature, the findings were disappointing 
since a single validated screening tool, or combination of screening tools that could be reliably 
used in the primary care setting to help determine which children require referral for OSA was 
not identified. Due to the wide range of sensitivity and specificity of signs and symptoms of 
childhood OSA, it is evident that the screening tools have insufficient accuracy when compared 
to PSG to determine which children have OSA. Thus, their utility is simply to acknowledge the 
signs, symptoms, and risk factors of childhood OSA through early recognition, and thereby 
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resulting in early referral. Overall, analysis and synthesis of the identified screening tools further 
validated the clinical practice guidelines recommendation for referral for PSG or to a sleep 
specialist or otolaryngologist in children that snore on a regular basis (Marcus et al., 2012). It 
remains that snoring has the highest sensitivity for OSA, thus, is it is the correct action to refer 
children whom snore on a regular basis to rule out OSA. As previously discussed, there are 
insufficient pediatric sleep services in BC, and as a result, a long wait list for pediatric PSG. The 
limitations of childhood OSA screening in the primary care setting and the associated burden of 
long wait times for referral and investigations, as well as the inaccessibility of these resources for 
many patients leads to delay in diagnosis and treatment for children with OSA. There is a need to 
bridge the gap between the delay in recognition of suspected OSA and investigations to confirm 
this diagnosis. Studies exploring home-based sleep studies for children provide an initial glimpse 
of the potential to improve pediatric sleep services. The following section will discuss the key 
aspects of home-based nocturnal oximetry used as a screening tool for suspected childhood OSA.  
Home-based Screening Tools  
 Currently, the screening tools outlined in the previous section focus on a child who is 
awake thereby limiting screening capability. OSA is difficult to assess in the primary care 
setting, since OSA occurs during sleep. Previous studies have evaluated the use of home sound 
and video recording of children during sleep to help identify OSA (Nixon & Brouillette, 2002; 
Sivan, Kornecki, & Schonfeld, 1996). While these studies are dated and deliver variable validity, 
they do bring forth the importance of assessing a child for OSA while asleep. Home-based 
screening tools identified as part of this integrative review focused on nocturnal oximetry sleep 
studies that provide metrics of sleep including oxygen saturation and pulse rate variability. The 
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primary advantage to home-based sleep studies is that these can provide evaluation of OSA 
while the child is asleep, in their home environment.  
 Three nocturnal oximetry studies analyzed in this integrative review include: automated 
analysis of nocturnal oximetry by Alvarez at al., (2015), the Phone Oximeter by Garde et al. 
(2014), and McGill Oximetry Score (MOS) used to determine likelihood of children undergoing 
adenotonsillectomy by Pavone et al. (2017). It is important to note that all three of these studies 
use algorithms for nocturnal oximetry, which is more advanced than simply counting 
desaturations. Pulse rate variability measures the time between two heartbeats; increased 
variability is linked to sympathetic nervous system activation which increases with hypopneas or 
apneic events. The algorithms utilized provide analysis of metrics of sleep that can be interpreted 
to determine OSA probability. Furthermore, as capturing the metrics of sleep is the goal of a 
sleep study, in contrast to oximetry in the hospital setting, there is no alarming of monitors or 
real-time intervention that is required during nocturnal sleep studies.  
 Analysis of the above three studies demonstrates that nocturnal oximetry can be 
accurately used as a screening tool, to identify children at high risk for OSA, and can provide 
important triage information to pediatric sleep specialists or otolaryngologists. Due to the high 
specificity, nocturnal oximetry has the additional advantage of functioning as a diagnostic tool 
for children with more severe OSA who have a positive sleep study (Alvarez at al., 2015). This 
provides primary care providers with concrete evidence that a referral is necessary. Furthermore, 
it conveys important triage information that may result in shorter wait time to see a specialist, 
and earlier treatment.  
 The use of home-based nocturnal oximetry screening for OSA requires a significant 
degree of parent participation and education. Primarily, the parents must understand the risk 
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factors and consequences of childhood OSA in order to be agreeable and accommodating to this 
type of screening in their home. Ideally, a respiratory therapist associated with a sleep centre 
would set up the nocturnal oximetry—as occurs with adult home sleep studies—and educate the 
parents on troubleshooting, and how to obtain the best study with minimal interruptions and 
artefact. An advantage to home based sleep studies are that they are performed in the comfort of 
the child’s home, in the same setting where the child sleeps each night, minimizing inconsistency 
variables, and mirroring a child’s typical night sleep. The main limitation to this type of 
screening is that children may not tolerate the oximetry probe, which could result in frequent 
removal and subsequent inconclusive sleep studies due to artefact or insufficient sleep time. This 
challenge could be overcome with play therapy. Furthermore, repeating home based nocturnal 
oximetry on subsequent nights until a conclusive study is achieved could be offered, and success 
may be more likely after the child is more comfortable with the sleep study process. Moreover, a 
child who does not tolerate home-based nocturnal oximetry would conceivably also not tolerate 
an in-laboratory PSG sleep study. Therefore, identifying a child’s response to home-based 
nocturnal oximetry can provide valuable information to sleep technologists regarding the 
feasibility of trying to obtain an in-laboratory PSG sleep study. While exact financial figures are 
unknown, it can be expected that the burden of repeated home based nocturnal oximetry studies 
would be associated with minimal cost in comparison to an in-laboratory PSG study at BC 
Children’s Hospital. Repeat home-based sleep studies could also be implemented to monitor 
children with primary snoring or mild OSA whom are at risk for developing more severe 
obstructive events secondary to obesity, increasing tonsil growth, or seasonal allergies.  
 Home-based nocturnal oximetry for children is not yet an option in BC. However, 
implementation of policies and clinical practice guidelines to support its use for children with 
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suspected OSA would improve efficiency and accuracy for referrals and treatment, which 
ultimately affects both primary and secondary levels of health care. Currently, when childhood 
OSA is suspected, a referral to an otolaryngologist or pediatrician is the first step for the primary 
care provider. However, if the results of a nocturnal oximetry sleep study were included in these 
referral letters, the specialists could improve their triage and management plans at the first visit, 
which would result in improved patient care. Improving pediatric sleep services, and 
collaborating with community resources, such as respiratory therapists, can allow primary care 
providers to expedite the diagnosis and treatment of suspected childhood OSA. The use of home-
based nocturnal oximetry also has the potential to involve primary care providers in improving 
their young patients health care outcomes in the tertiary setting prior to elective surgery. The 
presence of OSA places children at increased risk for perioperative respiratory adverse events 
(Tait, Voepel-Lewis, Christensen, & O’Brien, 2013). Anesthesiologists are responsible for 
assessing children for OSA prior to initiation of general anesthesia, however, their assessment is 
based on one snapshot in time and highly dependent on the parent’s report of snoring or troubled 
breathing during sleep. Therefore, children with risk factors for OSA, such as obesity, whom are 
undergoing surgery, could be assessed for OSA with home-based nocturnal oximetry pre-
operatively. Anesthesiologists could use this information to safely manage children and prevent 
perioperative respiratory adverse events.  
 The strength of home-based nocturnal oximetry is the role it has in fulfilling the unmet 
needs among the current trends of child health. With the rising epidemic of childhood obesity, 
and the strong correlation of obesity and OSA, it can be postulated that the incidence of 
childhood OSA will correspondingly rise. With more referrals for suspected childhood OSA, 
improved screening strategies at the primary care level are required to ensure children are being 
 67 
appropriately and efficiently referred and triaged when concerns are identified. A stepwise 
approach can help primary care providers screen for childhood OSA, and ensure resources such 
as nocturnal oximetry are used appropriately.  
Recommendations 
 This integrative review aimed to answer the question: what strategies can NPs, as primary 
care providers, implement to improve screening for OSA in children between the ages of 2-8 
years to determine need for referral? A literature review was conducted, and 11 key articles were 
analyzed and discussed. Three themes synthesized from the literature to help answer the above 
question were identified as: questionnaire based screening tools, objective variable screening 
tools, and home-based nocturnal oximetry screening tools. It is evident that more research is 
required, and both primary care providers and public health require improved awareness of the 
signs, symptoms, and risk factors of childhood OSA. Recommendations in regards to improving 
screening of childhood OSA will be outlined.   
Recommendations for Practice 
 Primary care providers who care for children must be aware of the risk factors, signs and 
symptoms, and associated morbidity of childhood OSA. Knowledge of the clinical indicators of 
childhood OSA facilitates early recognition and referral. A step-wise approach can be 
implemented towards the screening of childhood OSA in the primary care setting. 
Step 1: Recognition 
1. Ask about the presence of snoring at all health maintenance visits, as a universal screen 
for all children. 
2. Population specific screening: 
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• When any signs or symptoms of childhood OSA are identified (see Table 1). 
Emphasis should be placed on screening obese children, or those whom 
present with symptoms of hyperactivity, behavioural concerns, or classroom 
learning challenges.  
• Post adenotonsillectomy, assessing for residual OSA. 
Step 2: Utilize a validated screening tool to identify additional clinical indicators of childhood 
 OSA for children who snore on regular basis.  
Step 3: Referral 
• All children who snore on a regular basis or have any signs and symptoms of childhood 
OSA should be referred to an otolaryngologist or pediatric sleep specialist (Marcus et al., 
2012). Primary care providers must acknowledge the resources in their community, and 
the most appropriate specialist to accept a child with suspected OSA. For example, some 
communities may have a pediatric otolaryngologist, whereas others would first refer to a 
pediatrician, or general otolaryngologist. 
• During this step, the results of a home-based nocturnal oximetry sleep study would be 
exceedingly useful to include in a referral letter to help with triage. However, as 
nocturnal oximetry for children is not currently an option, parents can be encouraged to 
take a video of their child’s snoring and obstructive events during sleep, which can help 
primary care providers to gain additional insight of severity of OSA and can be conveyed 
in the referral letter.  
Recommendations for Education 
 This integrative review has brought the lack of primary care provider education regarding 
childhood OSA to the forefront. Early recognition of childhood OSA depends on the primary 
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care providers’ ability to recognize the risk factors and signs and symptoms of the condition. 
Thus, it is essential that both nurse practitioner programs and medical schools incorporate 
pediatric sleep medicine, including childhood OSA into their curriculums. Childhood OSA 
continuing education in the form of conference presentations, learning modules, and newsletters 
can reach currently practicing primary care providers whom are involved in the screening and 
care of children. Updates to the AAP Childhood OSA clinical practice guidelines require 
subsequent changes in the Rourke Baby Record and Greig Health Record to ensure the 
recommendations align. These changes must be communicated to primary care providers to 
ensure evidence-informed practice is promoted. When pediatric nocturnal oximetry becomes 
available and accessible as a screening tool for childhood OSA, respiratory therapists trained in 
setting up nocturnal oximetry for families would be valuable educators by engaging in academic 
detailing by visiting primary care offices. These education strategies can ensure primary care 
providers are up to date in current screening guidelines for childhood OSA. An additional 
important piece to education includes the education directed at the public and families, which 
will be discussed in the next section.  
Recommendations for Public Health  
 While primary care providers have the responsibility of screening children for OSA, 
parents and caregivers are also an important factor to the early recognition of childhood OSA. 
While not discussed directly within the reviewed studies, public health strategies must also be 
considered to improve awareness of childhood OSA. Therefore, a public health initiative framed 
within a population health approach would be beneficial towards improving the dissemination of 
knowledge regarding the signs and symptoms, risks, and consequences of childhood OSA. A 
public health strategy conveying the message that snoring during childhood requires 
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investigation would encourage parents to bring snoring concerns to their primary care provider. 
Parents can receive this information from a health care professional during immunizations and 
well child visits, and again at the entry into preschool or kindergarten. Awareness of the link 
between childhood OSA and hyperactivity, behavioural concerns, and learning difficulties in the 
classroom is also important for school teachers. Collaboration between public health and the 
school district can empower teachers to ask parents about sleep habits and snoring when a child 
demonstrates behavioural or learning concerns in the classroom and recommend they bring these 
issues to their primary care provider. A limitation to increasing public awareness of childhood 
OSA is that currently the demands for childhood OSA diagnostics exceed the availability. This 
highlights the need for research to support improved screening strategies for childhood OSA.  
Recommendations for Research 
 Childhood OSA is a condition that is currently under recognized. With primary care and 
public health strategies to improve early recognition, there must be infrastructure in place to 
support low barrier OSA screening. This integrative review determined that nocturnal oximetry 
can effectively be used to screen children for OSA, and with its high specificity can additionally 
be used as diagnostic for children with severe OSA (Alvarez at al., 2015; Garde et al., 2014). 
However, the crucial gap is that nocturnal oximetry in children has not yet been proven in 
practice. Research evaluating nocturnal oximetry in children’s own homes is the next step. This 
research should include quantitative studies evaluating the metrics of sleep and validity towards 
screening for OSA, as well as qualitative studies evaluating patients experience with using home-
based nocturnal oximetry. Additional strengths and limitations of the home-based nocturnal 
oximetry screening tools can be identified and explored with further research. If home-based 
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nocturnal oximetry proves to be feasible for children in practice, these studies can contribute to 
clinical practice guidelines supporting primary care led home-based sleep studies for children. 
 The main risk factors for childhood OSA are adenotonsillar hypertrophy and obesity. 
Adenotonsillar hypertrophy is recognized as the main risk factor for children less than 6 years of 
age, whereas obesity is the main risk factor for children greater than 6 years of age (Villa et al., 
2015). With increased prevalence of obesity in young children, there is a need for early 
intervention of OSA. There is a dearth of epidemiological research evaluating children <6 years 
of age with OSA primarily secondary to obesity. These children will have more complex 
treatment and follow-up needs than children <6 year of age with primary adenotonsillar 
hypertrophy associated OSA.  
 While diagnostic tools go beyond the scope of this integrative review, there are studies 
evaluating home-based sleep studies used primarily for diagnostic purposes (Brockmann et al., 
2013a; Marcus et al., 2014; Tan, Kheirandish-Gozal, & Goazal, 2015). Preliminary research has 
shown that home-based polysomnography (level 2 sleep studies) are technically acceptable for 
the diagnosis of OSA in children (Brockmann et al., 2013a; Marcus et al., 2014).  The area of 
pediatric home-based sleep studies is an up and coming area of research, which has the potential 
to improve health care costs and efficiency, as well as patient outcomes. Continued research on 
home-based sleep studies has the potential to bridge the gap in pediatric sleep services.  
A Call for Improved Pediatric Sleep Services 
 As previously acknowledged, sleep medicine is a developing subspecialty, and 
subsequently there are many gaps in the pediatric sleep services in BC (Ipsiroglu et al., 2008). 
Furthermore, current pediatric sleep services to diagnose childhood OSA are insufficient. 
Adenotonsillectomy is widely recommended as first line treatment for children with OSA. As 
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such, referral to an otolaryngologist when childhood OSA is suspected has historically been a 
logical first step. However, childhood obesity is a serious public health endemic with increasing 
prevalence; due to the strong connection between obesity and OSA it can be postulated that 
childhood OSA will also increase in prevalence. Treatment for children with OSA secondary to 
obesity is often more complex than adenotonsillectomy alone. Moreover, obese children are 
more likely to have residual OSA post adenotonsillectomy (Kaditis et al., 2015; Marcus et al., 
2012), and OSA secondary to obesity is likely a progressive condition. To minimize the sequelae 
associated with untreated childhood OSA, improved screening in the primary care setting is 
essential. 
 British Columbia needs improved screening strategies for childhood OSA, and this 
screening must be convenient and with limited burden on individual families and the health care 
system. Home-based nocturnal oximetry sleep studies provide valuable metrics of sleep that can 
be utilized for childhood OSA screening and in some contexts diagnosis. Home-based sleep 
studies allow for early recognition and prompt referrals and treatment, while eliminating the 
burden on in-laboratory PSG. This will in turn shorten the PSG waitlist for children who need it, 
such as children with craniofacial, neuromuscular, or genetic conditions predisposing them to 
OSA. Home-based nocturnal oximetry has the potential to improve pediatric sleep services in BC 
and address the burden of insufficient PSG. Further research and clinical practice guidelines 
supporting the use of home-based nocturnal oximetry is an effective strategy to improve 






 The main limitation of the studies analyzed in this integrative review is the 
inconsistencies in language for obstructive sleep apnea and sleep disordered breathing. These 
terms are often used interchangeably in the literature, which can result in a lack of clarity. 
Furthermore, throughout the literature different apnea/hypopnea index (AHI) cut-offs are used to 
define a diagnosis of OSA, as well as to describe the severity. Care was taken to eliminate 
discrepancies in language and by using AHI cut-offs instead of classifying OSA as mild, 
moderate, or severe when possible. 
Conclusion 
 Childhood OSA is an under recognized condition that is associated with complex 
neurodevelopmental, metabolic, and cardiovascular consequences. The main risk factors for 
childhood OSA include adenotonsillar hypertrophy and obesity. Early recognition is the 
cornerstone of decreasing the morbidity associated with childhood OSA. Primary care providers 
are responsible for screening children for OSA, and therefore should be knowledgeable about 
risk factors and clinical indicators of OSA, as well as clinical practice guideline 
recommendations towards screening for OSA. This integrative review aimed to answer the 
question: what strategies can NPs, as primary care providers, implement to improve screening 
for OSA in children between the ages of 2-8 years to determine need for referral? Review of the 
literature identified 11 studies evaluating screening tools for childhood OSA. Three themes were 
identified and discussed in detail: 1) use of validated pediatric OSA screening questionnaires; 2) 
use of subjective and objective variable risk stratification tools; and 3) the feasibility of home-
based nocturnal oximetry in children with suspected OSA. Synthesis of these screening tools 
identified clinical indicators that should be assessed and communicated in referral letters for 
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childhood OSA. Home-based nocturnal oximetry sleep studies show great potential as the next 
step towards improving childhood OSA screening and improving pediatric sleep services in BC. 
Consequently, home-based nocturnal oximetry in children is an area that requires further 
research to assess validity and reliability within the practice setting. This integrative review 
illuminates the importance of screening for childhood OSA in the primary care setting, and 
provides an outline of strategies primary care providers can implement to achieve early 




All citations are from Merriam-Webster Medical Dictionary retrieved in August 2017, unless 
otherwise indicated. 
 
Academic detailing: Academic detailing is an outreach education technique that combines the 
direct social marketing traditionally used by pharmaceutical representatives with unbiased 
content summarizing the best evidence for a given clinical issue. Academic detailing is 
conducted with clinicians to encourage evidence-based practice in order to improve the quality 
of care and patient outcomes (Yeh, Van Hoof, & Fischer, 2016). 
 
Adenotonsillar hypertrophy: the enlargement of the adenoids and tonsils (DelRosso, 2016). 
 
Adenotonsillectomy: operative removal of tonsils and adenoids. 
 
Apnea/hyponea index (AHI): the number of apneic and hypopneic episodes combined per hour 
of sleep. 
 
BC Children’s Hospital: a medical facility located in Vancouver, British Columbia, and is an 
agency of the Provincial Health Services Authority. It specializes in health care for patients from 
birth to age 16. BC Children's Hospital (BC Children's) provides expert health care, including 
mental health care, for the most seriously ill or injured children from across British Columbia 
(BC Children’s Hospital, 2017a). 
 
BiPAP: abbreviation for bilevel positive airway pressure; a trade name for a device that provides 
pressure support during non-invasive ventilation. 
 
Body mass index (BMI): a measurement of the relative percentages of fat and muscle mass in the 
human body, in which weight in kilograms is divided by height in meters squared and the result 
used as an index of obesity. 
 
CPAP: abbreviation for continuous positive airway pressure; a method of positive pressure 
ventilation used with patients who are breathing spontaneously, done to keep the alveoli open at 
the end of exhalation and thus increase oxygenation and reduce the work of breathing. 
 
ENT: abbreviation for ears, nose, throat; formally, otorhinolaryngology. 
 
Habitual snoring: Habitual snoring is the presence of snoring on more than three nights per week 
(Biggs et al., 2014b). 
 
Hypoxemia: insufficient oxygenation of the blood. 
 
Hypercapnia: excessive carbon dioxide in the blood; synonym, hypercarbia.  
 
Hypoxia: deficiency in the amount of oxygen reaching body tissues. 
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McGill Oximetry Score (MOS): McGill Oximetry Scoring System can be used to grade he 
severity of the apnea using pulse oximetry and looking for episodes of desatuation events 
(Pavone et al., 2017). 
 
Mild obstructive sleep apnea: Obstructive sleep apnea with an apnea/hypopnea index <5 
events/hour (Alonso-Alvarez et al., 2014). 
 
Moderate obstructive sleep apnea: Obstructive sleep apnea with an apnea/hypopnea index ≥ 
5/hour and < 10/hour (Alonso-Alvarez et al., 2014). 
 
Obesity: the condition of being obese; increased body weight caused by excessive accumulation 
of fat. 
 
Obstructive sleep apnea: “a disorder of breathing during sleep characterized by prolonged partial 
upper airway obstruction and/or intermittent complete obstruction (obstructive apnea) that 
disrupts normal ventilation during sleep and normal sleep patterns” (American Thoracic Society, 
1995, p. 866). 
 
Otolarynologist: a specialist in the disorders of the ear or nose or throat. 
 
Otolaryngology: the branch of medicine that deals with diagnosis and treatment of diseases of 
the ear, nose, and throat; also called otorhinolaryngology. 
 
Oximetry: a device for measuring the oxygen saturation of arterial blood, especially a pulse 
oximeter. 
 
Polysomnography: a sleep study that measures multiple physiologic variables associated with 
sleep. Includes oxygen saturation, electrocardiography, airflow, respiratory effort, limb 
movement, eye and jaw muscle movement, and brain electrical activity. 
 
Primary snoring: snoring without sleep apnea; habitual snoring (>3 nights/week) in the absence 
of apnea, frequent arousals, or gas exchange abnormalities (Li et al., 2013). 
 
Pulse rate variability: the measurement of time between two heartbeats; increased variability is 
linked to sympathetic nervous system activation which increases with hypopneas or apneic 
events (Pavone at al., 2017). 
 
Quality of life: a patient's general well-being, including mental status, stress level, sexual 
function, and self-perceived health status. 
 
Rapid-eye movements (REM): symmetric quick scanning movements of the eyes occurring 
many times during sleep in clusters for 5-60 minutes; associated with dreaming. 
 
Severe obstructive sleep apnea: obstructive sleep apnea with an apnea/hypopnea index ≥10/hour 
(Alonso-Alvarez et al., 2014). 
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Sensitivity: a “test's ability to correctly designate a subject with the disease as positive” (Maxim 
et al., 2014, p. 813). A highly sensitive test has few false negatives (type II error).  
 
Sleep disordered breathing: a series of disorders including snoring, obstructive sleep apnea 
(OSA), upper airway resistance syndrome (UARS), hypopnea, and obstructive sleep apnea-
hypopnea syndrome (OSHA). 
 
Sleep medicine: subspecialty of internal medicine that studies and manages sleep disturbances 
and disorders. 
 
Snoring: a harsh sound while breathing during sleep due to vibration of the soft palate. 
 
Specificity: a “test's ability to correctly designate a subject without the disease as negative” 
(Maxim et al., 2014, p. 813). A highly specific test has few false positives (type I error). 
 
SpO2: the saturation level of oxygen in hemoglobin; can be determined by noninvasive method 
of pulse oximetry. 
 
Ventilation: in respiratory physiology, the process of exchange of air between the lungs and the 
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Search Results  
















2 obstructive sleep apnea OR 
OSA OR sleep disordered 
breathing OR SDB 






3 screen* OR screening tools 







4 primary care  
(MeSH: primary health care) 
18,586 
 
113,639 2,417 39,651 
5 nurse practitioner*  





1 AND 2 698 2,242 
 
90 1,743 
1 AND 2 AND 3 130 231 
 
11 156 
1 AND 2 AND 4 7 51 0 14 
1 AND 2 AND 3 AND 4  
 
3 10 0 9 
1 AND 2 AND 3 AND 5 
 
0 1 0 0 
1 AND 2 AND 5 
 





Critical Appraisal Skills Program 
CASP: Cohort Study Checklist 
Are the results of the study valid? 
1. Did the study address a clearly focused issue? 
2. Was the cohort recruited in an acceptable way? 
3. Was the exposure accurately measured to minimise bias? 
4. Was the outcome accurately measured to minimise bias? 
5. (a) Have the authors identified all important confounding factors? 
    (b) Have they taken account of the confounding factors in the design and/or analysis? 
6. (a) Was the follow up of subjects complete enough?  
    (b) Was the follow up of subjects long enough? 
 
What are the results? 
7. What are the results of this study? 
8. How precise are the results? 
9. Do you believe the results? 
 
Will the results help locally? 
10. Can the results be applied to the local population? 
11. Do the results of this study fit with other available evidence? 
12. What are the implications of this study for practice? 
 
Note: Adapted from “12 questions to help you make sense of cohort study,” by Critical Appraisal 




















CASP: Systematic Review Checklist 
 
Are the results of the study valid? 
1. Did the review address a clearly focused question? 
2. Did the authors look for the right type of papers? 
3. Do you think all the important, relevant studies were included? 
4. Did the review’s authors do enough to assess the quality of the included studies? 
5. If the results of the review have been combined, was it reasonable to do so? 
 
What are the results? 
6. What are the overall results of the review? 
7. How precise are the results? 
 
Will the results help locally? 
8. Can the results be applied to the local population?  
9. Were all important outcomes considered? 
10. Are the benefits worth the harms and costs? 
Note: Adapted from “10 questions to help you make sense of a Systematic Review,” by Critical 





Synthesis of Screening Tools 
Subjective Clinical Features 
Clinical Feature Validity Inclusion in Screening Tool 
Snoring 
 
• High sensitivity, low 
specificity (Certal et al., 
2012) 
Snoring more than five 
nights/week 
• Sensitivity 76.7%, 
specificity 48.1 (Kang 
et al., 2015) 
Snoring >3 months  
• Sensitivity 83.6%, 
specificity 34.9% 
(Kang et al., 2015) 
 
1. PSSI (Biggs et al., 2014a) 
2. SRBD (Chervin et al., 2000) 
3. I’M SLEEPY (Kadmon et al., 
2014) 
4. Six hierarchically arranged 
questions (Spruyt & Gozal, 
2012) 
5. Sleep Clinical Record (Villa et 
al., 2013) 
 
Apnea/Witnessed Pauses  
 
• High specificity, low 
sensitivity (Certal et al., 
2012) 
• Sensitivity 42.2%, 
specificity 87.7% (Kang et 
al., 2015) 
1. SRBD (Chervin et al., 2000) 
2. I’M SLEEPY (Kadmon et al., 
2014) 
3. Clinical Risk Assessment Model 
(Kang et al., 2016) 
4. Six hierarchically arranged 
questions (Spruyt & Gozal, 
2012) 






• High specificity, low 
sensitivity (Certal et al., 
2012) 
1. PSSI (Biggs et al., 2014a) 
2. SRBD (Chervin et al., 2000) 
3. I’M SLEEPY (Kadmon et al., 
2014) 
4. Six hierarchically arranged 






• High specificity, low 
sensitivity (Certal et al., 
2012) 
• Sensitivity 19%, 




1. PSSI (Biggs et al., 2014a) 
2. SRBD (Chervin et al., 2000) 
3. I’M SLEEPY (Kadmon et al., 
2014) 






• Sensitivity 20.7%, 
specificity 75.5% (Kang et 
al., 2015) 
1. SRBD (Chervin et al., 2000) 







• Sensitivity 19.0-41.4%, 
specificity 57.5-84.0% 
(Kang et al., 2015) 
1. SRBD (Chervin et al., 2000) 
2. I’M SLEEPY (Kadmon et al., 
2014) 
 
Low mood/ irritability 
 
• Sensitivity 0.9%, 
specificity 98.1% (Kang et 
al., 2015) 
1. PSSI (Biggs et al., 2014a) 
2. SRBD (Chervin et al., 2000) 






1. SRBD (Chervin et al., 2000) 
2. Sleep Clinical Record (Villa et 
al., 2013) 
 
• Mouth breathing (adenoidal hypertrophy) 1. SRBD (Chervin et al., 2000) 
2. Sleep Clinical Record (Villa et 
al., 2013) 
 
• Awakening 1. PSSI (Biggs et al., 2014a) 
 
• Headaches  1. SRBD (Chervin et al., 2000) 
2. Sleep Clinical Record (Villa et 
al., 2013) 
 
• Restless sleep 1. PSSI (Biggs et al., 2014a) 
 
Objective Clinical Features 
Clinical Feature Validity Inclusion in Screening Tool 
Obesity • Sensitivity 28.4%, 
specificity 85.8% (Kang et 
al., 2015) 
1. SRBD (Chervin et al., 2000) 
2. I’M SLEEPY (Kadmon et al., 
2014) 
3. Clinical Risk Assessment Model 
(Kang et al., 2016) 
4. Sleep Clinical Record (Villa et 
al., 2013) 
 
Tonsillar hypertrophy • High sensitivity (Certal et 
al., 2012) 
• Sensitivity 76.7%, 
specificity 65.1% (Kang et 
al., 2015) 
1. I’M SLEEPY (Kadmon et al., 
2014) 
2. Clinical Risk Assessment Model 
(Kang et al., 2016) 




Adenoid Size • Sensitivity 75.0%, 
specificity 55.7% (Kang et 
al., 2015) 
1. I’M SLEEPY (Kadmon et al., 
2014) 
2. Clinical Risk Assessment Model 
(Kang et al., 2016) 




• Nasal obstruction  
• Septum nose deviation 
• Dental/skeletal malocclusions  
• Mandible angle  
• Open-bite, deep-bite, cross-bite; over-bite  
• Palate position (Friedman) 
• Narrow palate 







Summative Table of Childhood OSA Screening Tools 
Most sensitive clinical indicator: Snoring 
Most specific clinical indicator: Apnea/witnessed pauses 
 
Questionnaire Based Screening Tools  
Screening Tool Details AHI cut-off Sensitivity Specificity Practicality  
I’M SLEEPY 
(Kadmon et al., 2014) 
8-item questionnaire. 
≥3 = positive screen  
AHI ≥1.5 
events/hour 
82% 50% Brief questionnaire.  
Easy to remember mnemonic.  
SRBD (Chervin et al., 
2000) 
22-item questionnaire 
≥8 = positive screen  
AHI ≥5 
events/hour 
83% 87% Lengthy questionnaire.  
Print out copy to give to family member to 
complete.   
PSSI (Biggs et al., 
2014a) 
45-item questionnaire 




94% 76% Lengthy questionnaire.  
Print out copy to give to family member to 
complete. 










59% 83% Brief list of questions. Yes to an answer high 
on the hierarchy increases likelihood of OSA.  
Subjective and Objective Variable Screening Tools 
Screening Tool Details AHI cut-off Sensitivity Specificity Practicality  
Clinical Risk 
Assessment Model 
(Kang et al., 2016) 
Score >10 is mild OSA Mild 73% 65% Limitation: Requires lateral cephalometric 
radiographs to obtain adenoid size.  





Sleep Clinical Record 
(Villa et al., 2013) 
≥6.25 is a positive result >1 event/hour 96% 67% Limitation: Subjective nature of many of the 
anatomical findings included in this tool. 
Difficulty in objectively grading severity of 
narrow palate renders this screening tool 
open to subjective interpretation from 
different providers. 
